Synergistic herbal compositions for treatment of obesity and overweight

A synergistic herbal composition derived from Theobroma cacao and Citrus aurantifolia inhibits adipogenesis and promotes lipolysis, effectively reducing obesity and overweight by enhancing browning of white adipose tissue and increasing metabolic rate.

JP2024156692AActive Publication Date: 2024-11-06LAILA NUTRACEUTICALS
View PDF 11 Cites 0 Cited by

Patent Information

Application Number
JP2024111411
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-03-05
Filing Date
2024-07-11
Publication Date
2024-11-06
Estimated Expiration
2039-03-05

AI Technical Summary

Technical Problem

There is a need for highly effective herbal compositions that can prevent, control, or treat obesity and overweight while improving lean body mass, enhancing browning of white adipose tissue to brown adipose tissue, increasing basal metabolic rate, stabilizing energy expenditure, and promoting weight loss without harmful side effects.

Method used

A synergistic herbal composition comprising extracts and fractions derived from Theobroma cacao and Citrus aurantifolia, combined with pharmaceutically acceptable excipients, to inhibit adipogenesis, promote lipolysis, and enhance thermogenesis, browning of white adipose tissue, and increase metabolic rate.

Benefits of technology

The composition effectively reduces body weight, fat mass, and improves metabolic health by inhibiting adipogenesis, increasing lipolysis, and inducing browning of white adipose tissue, leading to reduced body weight and improved energy expenditure.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024156692000018
    Figure 2024156692000018
  • Figure 2024156692000019
    Figure 2024156692000019
  • Figure 2024156692000020
    Figure 2024156692000020
Patent Text Reader

Abstract

To provide synergistic herbal compositions for treatment of obesity and overweight.SOLUTION: The invention discloses synergistic herbal composition comprising combination of first ingredient selected from extracts, fractions, phytochemicals and mixtures thereof derived from Theobroma cacao and a second ingredient selected from extracts, fractions, phytochemical and mixtures thereof derived from Citrus aurantifolia for obtaining at least one health benefit selected from preventing, controlling or treating obesity and / or overweight; improving lean body mass, improving the browning of white adipose tissue / improving formation of brown adipose tissue, increasing basal metabolic rate / resting energy expenditure, increasing thermogenesis, improving thyroid function, maintaining healthy body weight, increasing satiety, supporting weight loss, improving fat loss and maintaining a slim body.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention provides a method for preventing, controlling, or treating obesity and / or overweight, and improving lean body mass. Improves the browning of white adipose tissue (WAT) and promotes the formation of brown adipose tissue (BAT) Improves metabolism, increases basal metabolic rate (BMR) / stabilizes energy expenditure and increases heat production Improves thyroid function, maintains healthy weight, increases satiety and aids in weight loss , improving fat loss, and maintaining lean body mass. Derived from Theobroma cacao to obtain the benefits of a first component selected from the group consisting of extracts, fractions, phytochemical components and mixtures thereof; Derived from Citrus aurantifolia and a second component selected from the group consisting of extracts, fractions, phytochemical components and mixtures thereof. and a pharma- ceutically acceptable excipient, diluent, and carrier, or a combination thereof. The present invention relates to a synergistic herbal composition optionally containing at least one ingredient selected from the group consisting of phenoxyethanol and phenylalanine. The present invention also provides extracts, fractions, phytochemical components and compositions derived from Theobroma cacao. A first component selected from the above mixture and a component derived from Citrus aurantifolia. and a second component selected from the group consisting of extracts, fractions, phytochemical components and mixtures thereof. and a pharma- ceutically acceptable excipient, diluent, and carrier, or a combination thereof. A synergistic herbal composition optionally containing at least one ingredient selected from the group consisting of sucrose, ... The use of the product can be used to prevent, control, or reduce obesity and / or overweight in humans. improves lean body mass and enhances browning of white adipose tissue (WAT) / brown adipose tissue (BR). Improves the formation of adipose tissue (BAT) and increases basal metabolic rate (BMR) / energy expenditure Stabilizes mass, improves thermogenesis, enhances thyroid function, maintains healthy weight and satiety Choose from increasing blood sugar, aiding in weight loss, increasing fat loss and maintaining lean body mass. The present invention relates to a method for obtaining at least one health benefit from [Background technology]

[0002] Obesity and overweight are rapidly growing conditions in an increasing number of countries around the world. A recent WHO report stated that global obesity rates have tripled since 1975.30 kg / m 2 A person with a body mass index (BMI) above 100 is generally considered to be overweight. and overweight is 25 kg / m 2 Those who have been confirmed to have a BMI of 100 or above Both conditions are caused by an imbalance between energy intake and expenditure. Obesity is associated with substantial increases in morbidity and premature mortality, reduced quality of life, and Excess weight is associated with increased risk of diabetes, metabolic syndrome, Hypertension, dyslipidemia, myocardial infarction, stroke, certain cancers, sleep apnea and osteoarthritis This increases the likelihood of developing weight loss. Key strategies include reducing food consumption or absorption and / or increasing energy expenditure. Many drugs have been commercialized as an answer to the obesity problem. Most have been withdrawn from the market due to unacceptable side effects. Researchers in the field of metabolic disorders are looking to treat obesity / overweight and related diseases, and are looking to address the issue of food. The focus has been on the components derived from the plant and marine kingdoms. Some herbal extracts and dietary ingredients have been shown to have effects on appetite regulation, fat oxidation, energy intake or thermogenesis. Herbal ingredients have been shown to have few harmful side effects. These are known to have benefits that make them an interesting complementary approach to the management of obesity. may present with roaches.

[0003] Patent Document 1 discloses Alchemilla vulgaris, Olea europaea, Cuminum simum num cyminum) and Mentha longifolia lora) (weight ratio 12:10:5:4) and Theobroma cacao, caffeine In anhydrous, Coffea Arabica, Coffea canef Coffea canephora, Camellia sinensis sinensis), Ilex paragua riensis), guarana, and kona is doing.

[0004] Patent Document 2 discloses the use of theobroma for treating receptor tyrosine kinases associated with disorders. -Discloses cocoa extract.

[0005] Patent document 3 targets psoriasis and other skin diseases such as acne and fungal diseases. Cucumis sativus, Citrus aurante ifolia, Pimenta racemosa and Clapton Aqueous liquid extraction of Graptophyllum pictum leaves The present invention discloses a composition containing the

[0006] Patent Document 4 discloses at least one fermented food product containing catechin and theobroma cacao extract as a source. It discloses a dietary supplement containing 3% corosolic acid to promote weight loss.

[0007] Patent Document 5 discloses Zingiber officinale ), Cotinus coggygria, Citrus oleracea Citrus aurantium, Lupron, Whey Protein Monohydrate Polynicotinic acid chromium, hexahydroisoalpha-acid, xanthohumol, roi Soybean Acids, Elderberry, Gymnema sylvestre ), Camellia sinensis, Acacia nilotica , Malus pumila, Ribes nigrum L igrum L), Hypericum perforatum (Hypericum perfo ratum), Theobroma cacao, Vaccinium myrtillus, Camellia sinensis, Rosa canina ( Rosa canina, isoalpha acid, vaccinium erythrocarpam (Vac cinium erythroCarpum), leucine, goldenseal canadensis (Hydrastis Canadensis), Vitis vinifera (Viti s vinifera), Rhamnus purshiana ), Epimedium (Hortonii Gourdweed), Curcuma longa longa), Opuntia ficus indica (Opuntia ficus i ndica), Syzygium cumini and Tetrahymena A group of phytochemical components or extracts isolated from doloisoalpha acid, which are pharma- ceutical active agents. By using a composition containing one or more components in an amount, AMPs, which are elastic cells in animals, can be A method for activating K is disclosed.

[0008] Another patent document 6 discloses a method for the treatment of a pulmonary edema by using effective amounts of green tea, ginger, caffeine, cocoa, calcium, and yucca. Ruba Mate, Hawthorn Berry, Parsley Leaf Marshmallow Root, Fennel Seed, Astragalus Root, licorice root, sorrel, cinnamon, celery seed and alfalfa leaf, The present invention discloses a tablet formulation.

[0009] Therefore, alternative methods, including highly effective herbal compositions, for the management of obesity and overweight are available. There is a continuing need in the art to provide effective treatments. Herbal extracts and compositions that are well tolerated and more effective than ever before are useful in treating obesity and There is an urgent need for more consideration regarding overweight. [Prior art documents] [Patent documents]

[0010] [Patent Document 1] U.S. Patent Publication No. 2016 / 045560(A1) [Patent Document 2] International Publication No. WO2016 / 046375(A1) [Patent Document 3] International Publication No. WO2008 / 110853(A1) [Patent Document 4] Australian Patent Publication No. 2006312947(B2) [Patent Document 5] U.S. Patent Publication No. 2010 / 0112099(A1) [Patent Document 6] U.S. Patent No. 7,329,419 (B2) Summary of the Invention [Problem to be solved by the invention]

[0011] Objective of the invention The object of the present invention is to prevent, control or treat obesity and / or overweight and to increase lean body mass. Improves weight and promotes browning of white adipose tissue (WAT) / brown adipose tissue (BAT) Improves metabolism, increases basal metabolic rate (BMR) / stabilizes energy expenditure, and reduces body heat Increases cholesterol production, improves thyroid function, maintains a healthy weight, increases satiety and supports weight loss and at least one health benefit selected from: supporting a person's overall health, improving fat loss, and maintaining lean body mass. Extracts, fractions and phytochemical constituents derived from Theobroma cacao for health benefits and mixtures thereof, and a first component selected from Citrus aurantifolia or The second component is selected from the group consisting of extracts, fractions, phytochemical components and mixtures thereof derived from the plant. The present invention provides a synergistic herbal composition comprising a combination of

[0012] Another object of the present invention is to provide a method for preventing or controlling obesity and / or overweight in humans or animals. Control or treat to improve lean body mass and enhance browning of white adipose tissue (WAT) / Improves the formation of brown adipose tissue (BAT) and increases the basal metabolic rate (BMR) / Energy Stabilizes ghee consumption, improves thermogenesis, enhances thyroid function, maintains healthy weight and satiety Increases abdominal tone, aids in weight loss, and provides a way to improve fat loss and maintain a lean body The method comprises the steps of: preparing extracts, fractions, phytochemicals, and the like derived from Theobroma cacao; A first ingredient selected from the group consisting of ingredients and mixtures thereof, and Citrus aurantifolia A second component selected from extracts, fractions, phytochemical components and mixtures thereof derived from The present invention relates to a method for treating a chronic inflammatory condition, comprising the steps of: supplementing a human with an effective amount of a synergistic herbal composition comprising a combination of ingredients comprising:

[0013] Yet another object of the present invention is to provide a method for preventing, controlling, or treating obesity and / or overweight, Improves lean body mass and promotes browning of white adipose tissue (WAT) / brown adipose tissue (BAT) Improves the formation of AT, increases basal metabolic rate (BMR) and stabilizes energy expenditure Increases thermogenesis, improves thyroid function, helps maintain a healthy weight, increases satiety, At least one selected to help you lose weight, increase fat loss and maintain lean body mass Extracts, fractions and botanicals derived from Theobroma cacao to obtain three health benefits A first component selected from the group consisting of citrus aurantifolia and mixtures thereof. The present invention relates to a method for the preparation of a phytochemical composition comprising the steps of: extracts, fractions, phytochemical components and mixtures thereof derived from The present invention provides for the use of a synergistic herbal composition comprising a combination of two ingredients. [Means for solving the problem]

[0014] Summary of the Invention The present invention provides a method for preventing, controlling, or treating obesity and / or overweight, and improving lean body mass. Improves the browning of white adipose tissue (WAT) and promotes the formation of brown adipose tissue (BAT) Improves metabolism, increases basal metabolic rate (BMR) / stabilizes energy expenditure and increases heat production Improves thyroid function, maintains healthy weight, increases satiety and aids in weight loss , improving fat loss, and maintaining lean body mass. Theobroma cacao-derived extracts, fractions, phytochemicals and and mixtures thereof; and a first component selected from Citrus aurantifolia. A second component selected from derived extracts, fractions, phytochemical components and mixtures thereof. The present invention provides a synergistic herbal composition comprising a combination of:

[0015] Another aspect of the invention is a method for preventing, controlling, or treating obesity and / or overweight in humans. Treat and improve lean body mass and enhance browning of white adipose tissue (WAT) / brown fat Improves the formation of BAT tissue and increases basal metabolic rate (BMR) / energy expenditure It stabilizes the body's natural metabolism, improves thermogenesis, enhances thyroid function, helps maintain a healthy weight and promotes satiety. Choose from: Increase your body fat, aid in weight loss, improve fat loss and maintain lean body mass The present invention provides a method for obtaining health benefits from an extract derived from Theobroma cacao. a first component selected from the group consisting of Citrus aurantifolia, a citrus extract, a citrus syrup, a citrus syrup, and a mixture thereof; A combination of a second component selected from extracts, fractions and mixtures thereof derived from the leucocyte. The present invention relates to a method for the treatment of atopic dermatitis, comprising the steps of: feeding a human an effective amount of a synergistic herbal composition comprising: At least one component selected from excipients, diluents, and carriers thereof may be optionally selected. This includes.

[0016] Another aspect of the invention is a method for preventing, controlling, or treating obesity and / or overweight in humans. Treat and improve lean body mass and enhance browning of white adipose tissue (WAT) / brown fat Improves the formation of BAT tissue and increases basal metabolic rate (BMR) / energy expenditure It stabilizes the body's natural metabolism, improves thermogenesis, enhances thyroid function, helps maintain a healthy weight and promotes satiety. Choose from: Increase your body fat, aid in weight loss, improve fat loss and maintain lean body mass , an extract derived from Theobroma cacao to obtain at least one health benefit. a first component selected from the group consisting of Citrus aurantifolia, a citrus extract, a citrus syrup, a citrus syrup, and a mixture thereof; A combination of a second component selected from extracts, fractions and mixtures thereof derived from the leucocyte. The present invention provides a method for the preparation of a synergistic herbal composition comprising administering to a patient a therapeutically effective amount of the above-mentioned compound, ... and Optionally, it comprises at least one component selected from diluents, and carriers thereof.

[0017] Other aspects of the invention include extracts, fractions and their preparations derived from Theobroma cacao. A first component selected from the mixture and an extract derived from Citrus aurantifolia. and a second component selected from the group consisting of extracts, fractions and mixtures thereof. providing a synergistic herbal composition and improving metabolic processes, e.g., promoting lipolysis; and inhibition of adipogenesis, increase in fibroblast growth factor-21 (FGF-21), uncoupling protein Increased protein (UCP-1) and increased β3-adrenergic receptors (β3-ARs) At least one selected from pharma- ceutically acceptable excipients / diluents and their carriers for The composition may optionally contain at least one component. [Brief description of the drawings]

[0018] [Figure 1]Bar diagram showing the weight of animals in control and treatment groups (A) on days 1, 8, 15, 22 and 28. Each bar represents the mean weight ± SM. p<0.05 is significant, # is G1 vs. G2, * is G2 vs. treatment group. Bar diagram showing the percentage change in weight of animals in control and treatment groups (B) on day 28. G1 and G2 represent the groups of rats supplemented with normal chow and high-fat chow, respectively. G3, G4 and G5 represent the groups of rats supplemented with 100 and 300 mg / kg body weight of Composition-67 and high-fat chow with 10 mg / kg body weight of Sibutramine, respectively. [Diagram 2] The bar diagram shows the reduction in daily dietary calorie intake by diet-induced obese rats supplemented with composition 67. Each bar represents the mean ± SD. G1 and G2 represent groups of rats supplemented with normal diet and high fat diet. G3, G4 and G5 represent rats supplemented with 100 and 300 mg / kg body weight of composition 67 and high fat diet with 10 mg / kg body weight of sibutramine, respectively. n=7, p<0.05 significant, # is G1 vs. G2, * is G2 vs. treatment group. [Diagram 3] The bar diagram shows the reduction of visceral fat mass in diet-induced obese rats supplemented with composition 67. Each bar represents the mean ± SD. G1 and G2 represent groups of rats supplemented with normal diet and high-fat diet. G3, G4 and G5 represent rats supplemented with 100 and 300 mg / kg body weight of composition 67 and high-fat diet with 10 mg / kg body weight of sibutramine, respectively. n=7, p<0.05 significant, # is G1 vs. G2, * is G2 vs. treatment group. [Figure 4]The bar graph shows the change in epididymal adipocyte size in diet-induced obese rats supplemented with Composition 67. Each bar represents the mean ± SE of adipocyte area in μm2. G1 and G2 represent the groups of rats supplemented with normal diet and high-fat diet, respectively. G3, G4 and G5 represent the groups of rats supplemented with Composition 67 at 100 and 300 mg / kg body weight and high-fat diet with sibutramine at 10 mg / kg body weight, respectively. n=7, p<0.05 significant, # is G1 vs. G2, * is G2 vs. treatment group. [Diagram 5] The bar diagram shows the normalization of serum leptin levels in diet-induced obese rats supplemented with composition 67. G1 and G2 represent the groups of rats supplemented with normal diet and high-fat diet, respectively. G3, G4 and G5 represent the rats supplemented with 100 and 300 mg / kg body weight of composition 67 and high-fat diet with 10 mg / kg body weight of sibutramine, respectively. n=7, p<0.05 significant, # is G1 vs. G2, * is G2 vs. treatment group. [Figure 6] The bar diagram shows the improvement of thyroid hormone balance in diet-induced obese rats supplemented with composition 67. Each bar represents the mean ± SD of triiodothyronine (T3) and thyroxine (T4) ratio. G1 and G2 represent groups of rats supplemented with normal diet and high-fat diet, respectively. G3, G4 and G5 represent groups of rats supplemented with 100 and 300 mg / kg body weight of composition 67 and high-fat diet with 10 mg / kg body weight of sibutramine, respectively. n=7, and the number on each bar represents the percentage of relative T3 / T4 ratio, which is considered to be 100% in G1. [Figure 7] Photomicrographs show immunohistochemical staining of UCP-1 in epididymal adipose tissue. G1 and G2 represent groups of rats supplemented with normal diet and high-fat diet, respectively. G3, G4 and G5 represent rats supplemented with 100 and 300 mg / kg body weight of composition 67 and high-fat diet with 10 mg / kg body weight of sibutramine, respectively. Bar: 50 μm. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0019] Detailed Description of the Invention The present invention will now be described in detail with reference to certain preferred and optional embodiments. so that their various aspects may be fully understood and appreciated.

[0020] The terms "adipolysis" and "lipolysis" are art-recognized terms and These terms are used interchangeably throughout this specification. Those skilled in the art will recognize similar terms as such. Similarly, browning, browning of fat, beige fat and white fat Browning of adipose tissue (WAT) is also used interchangeably. The terms "herb" and "plant" are The terms "product" and "item" are also used interchangeably throughout this specification.

[0021] Adipogenesis is the process of differentiation and proliferation of preadipocytes into mature adipocytes or fat cells. In this process, preadipocytes or preadipocytes are transformed into mature adipocytes. After differentiation into the adipocyte phenotype, they proliferate. The nuclear receptor PPARγ mediates adipocyte differentiation and adipose tissue proliferation. Adipocytes are known to play an important role in fat deposition. It plays an essential role in the metabolism of large amounts of glycerol, such as triglycerides in animals. Fat cells exist in a dynamic state and they When consumption exceeds intake, hypertrophy begins. This process is unique to these cells. It is highly regulated by antagonistic hormones that are always highly sensitive. Harm is one of the major goals of developing treatments for obesity / overweight and promoting weight loss. be.

[0022] Adipolysis (lipolysis) is the breakdown of triglycerides stored in fat cells. This is a metabolic process that promotes the release of fatty acids and glycerol into the bloodstream. It is a tightly regulated process that allows for proper delivery of free fatty acids and thus energy Therefore, increasing adipolysis can treat and reduce obesity / overweight. One of the main goals of the treatment is to promote the release of β3-adrenergic receptors. It can stimulate lipolysis in colored adipose tissue and thermogenesis in brown adipose tissue. Plant extracts, fractions and phytochemical agents with lipolytic activity are effective in treating obesity, overweight and other conditions. and other metabolic disorders.

[0023] Therefore, the inventors of the present application have demonstrated that the anti-adipogenic and pro-adipogenic activity of In order to screen many plant extracts and fractions randomly, Theobroma cacao and The extracts and fractions derived from Citrus aurantifolia are summarized in Tables 3 to 7. As shown in Fig. 1, the effective dose was dependent on anti-adipogenic and preadipocyte activity. I put it out.

[0024] A brief summary of each of the plant materials is provided herein below.

[0025] Theobroma cacao: Theobroma cacao L. is a small but economically important tree. It is an evergreen tree of the Sterculiaceae family, 4-8m tall, native to the tropical regions of America. Cacao seeds are an important source of polyphenols and theobromine. Used to make cocoa mass, cocoa powder, confectionery, gouache and chocolate Cocoa extract or its phytochemical components have been shown to be effective in preventing platelet aggregation, hypertension, and atherosclerosis. Atherosclerosis, hyperglycemia and hypercholesterolemia, inflammation, liver cancer formation, DNA damage and showed some beneficial effects on clastogenicity. Theobromine (I) is the principle alkaloid in Theobroma cacao (Donald L. Pavi a,Journal of Chemical Education,1973,50, 791-792) and the extract used in the present invention was found to be theobromi by HPLC analysis. It is standardized in

[0026] [ka]

[0027] Citrus aurantifolia: Citrus aurantifolia grows to a height of 3-5m. It is a perennial evergreen tree that can grow to a height of 100m. It has irregularly thin branches and short, It has strong, sharp thorns or needles. The flowers are short, partly white, and fragrant. The fruits are round, 3-5 cm in diameter, and yellow when ripe. Classification of S. aurantifolia: Kingdom (Plantaceae), Infrakingdom (Vascular plants), Superkingdom (Seed plants) ), Phylum(Angiosperms), Class(Magnoliaceae), Subclass(Rosaceae), Order(Sapindales), Family(Milk) Family: Citrus, Genus: Citrus, Species: Citrus aurantifolia. It is found in India, China, They are native to tropical and subtropical regions of Asia and Southeast Asia, including North Africa, The common name for Citrus aurantifolia is lime. (English). It is used not only as a flavoring in beverages, processed foods, and dosage forms, but also as a It is also used as an ingredient in perfumes. The peel of Citrus aurantifolia has antioxidant properties. Antidiabetic activity, antilipidemic activity, anti-insecticide activity, anti- It has traditionally been used as a potent anti-cancer drug, as it inhibits xanthine oxidase in vitro. It has been shown to have inhibitory, antioxidant, cytotoxic and antiviral effects. Limonin (II) is found in Citrus aurantifolia and other cosmetics. The extract of the present invention was confirmed to be the principal metabolite of ribavirin by HPLC analysis. Standardized to monin(II).

[0028] [ka]

[0029] The sources of herbs used in the present invention are as follows:

[0030] 1. Theobroma cacao seeds are from Aswaraopeta Village, Aswaraopet a Panchayat, Aswaraopeta District, Bhadradri Kothagud It was collected from cultivated sources in em district, Telangana state.

[0031] 2. Citrus aurantifolia is found in Rayapudi village, Rayapudi pan Chayat, Thullur upazila, Guntur district, Andhra Pradesh Collected from cultivated sources in the country.

[0032] Theobroma cacao seeds were crushed and the powder was dissolved in water, aqueous ethanol, ethanol, aqueous methanol, etc. Extraction was performed using various solvents, such as ethanol and n-butanol, and the aqueous extracts were (TC-1), aqueous ethanol extract (TC-2), ethanol extract (TC-3 ), aqueous methanol extract (TC-4) and n-butanol extract (TC-5). Theobroma cacao seed extract was found to contain theobromine by HPLC analysis. The results are summarized in Table 1. The fruit peel was crushed and the powder was dissolved in aqueous ethanol, ethanol, water, aqueous methanol and n- butanol, and aqueous ethanol extracts (CA -1), ethanol extract (CA-2), water extract (CA-3), aqueous methanol extract The Citrus oleifera extract (CA-4), and n-butanol extract (CA-5) were obtained. The extract of L. lantifolia was standardized for limonin (II) by HPLC analysis. The results are summarized in Table 2.

[0033] Theobroma cacao seed extract and Citrus aurantifolia fruit extract The skin extract was used in an in vitro cell model in mouse 3T3-L1 preadipocyte cells. , were evaluated for their anti-adipogenic & pro-adipogenic activities. He pointed out that it is highly effective in inhibiting adipogenesis and increasing adipolysis. For example, the aqueous extract of Roma cacao seeds (TC-1) was found to be effective at 5 μg / mL and 10 μg / mL. At the treatment concentration of 1 mL, the results showed 38.36% and 41.10% inhibition of adipogenesis, respectively. The aqueous ethanol extract of Citrus aurantifolia fruit peel (CA-1) At treatment concentrations of 5 μg / mL and 10 μg / mL, 25.81% and 35.74% Theobroma cacao seeds and Citrus oleracea showed inhibition of adipogenesis, respectively. Other solvent extracts of the peel of the Tifolia fruit have also been found to be effective.

[0034] These individual extracts or fractions thereof are then analyzed to determine the synergistic effectiveness between these components. Theobroma cacao extracts or fractions were evaluated to investigate the possibility of Extracts or fractions derived from Citrus aurantifolia and Citrus aurantifolia were analyzed in different ratios. The compositions (Compositions 1 to 65) were obtained by mixing in the ratio of 1 to 65 (C-1 to C-65). 65) was compared with the corresponding individual components to test their inhibitory effects on adipogenesis. Data from an in vitro adipogenesis inhibition assay for compounds derived from Theobroma cacao The derived extract(s), or fraction(s), or phytochemical components or mixtures thereof The mixture is an extract(s) or fraction(s) derived from Citrus aurantifolia. or phytochemical ingredients or mixtures thereof that exhibit synergistic properties when combined with The inhibition of adipogenesis when compared to their corresponding individual components suggests that The study showed unexpectedly favorable efficacy in terms of harm.

[0035] For example, the water extract of Theobroma cacao seeds (TC- 1) and 50% of Citrus aurantifolia fruit peel at a concentration of 3.33 μg / mL. % aqueous ethanol extract (CA-1) increased adipogenesis by 15.23% and 19.47% The inhibition of theobroma cacao seeds was observed at 5 μg / mL and in a 1:2 ratio. (TC-1) and 50% aqueous extract of Citrus aurantifolia fruit peel. Composition-2 containing the ethanol extract (CA-1) showed 44.78% inhibition of adipogenesis. This was 34.7% inhibition calculated from the inhibition exhibited by the corresponding individual components. This is significantly better than the additive effect of these two extracts (15.23% + 19.47%). The products (TC-1 and CA-1) were mixed at 1:3, 1:1, 2:1 and 3:1 ratios, respectively. Composition-1 (C-1) and Compositions-3 to 5 (C-1 and C-3) ~C-5) are also calculated by the respective concentrations of the corresponding individual components, as summarized in Table 3. When compared with the inhibition shown, synergy was demonstrated. Citrus aurantifolia peel ( of Theobroma cacao seeds combined with other solvent extracts (CA-2~CA-5) Other compositions (C6-C19) containing the water extract (TC-1) also showed synergistic lipid The results showed inhibition of adipogenesis (Table 3).

[0036] An additional example is the 50% aqueous ethanol solution of Theobroma cacao seeds at a concentration of 0.83 μg / L. Nol extract (TC-2) and Citrus aurantifolia at a concentration of 1.67 μg / L The 50% aqueous ethanol extract of the bark of A. foria (CA-1) had 2.07% and 26.4% At 2.5 μg / mL, Theobroma cacao inhibited lipogenesis by 6%. A 50% aqueous ethanol extract of seeds (TC-2) and Citrus aurantifolia The composition contains 50% aqueous ethanol extract of barley peel (CA-1) in a ratio of 1:2. Composition-21 showed 40.19% inhibition of adipogenesis, which was comparable to the corresponding individual components. The additive effect of 28.53% (2.07% + 26.46%) was calculated from the inhibition shown by These two extracts (TC-2 and CA-1) were significantly better than those of other Composition-20 and Composition-22 to 24 (C-20, C-2 2-C-24) and Citrus aurantifolia fruit peel and other solvent extracts. Contains 50% aqueous ethanol extract of combined Theobroma cacao seeds (TC-2) The compositions used are also summarized in Table 4, with each of the corresponding individual component concentrations. This demonstrated synergy when compared to the inhibition shown by

[0037] Similarly, other solvent extracts of Theobroma cacao and Citrus aurantifolia The compositions (C-39 to C-65) containing the above-mentioned components have the corresponding individual component concentrations as summarized in Table 5. The results show synergy when compared to the inhibition exhibited by each of the two.

[0038] The compositions (Compositions 1-65) showed a significantly increased cytotoxicity in mouse 3T3-L1 cells compared to the corresponding individual components. Efficacy of increasing adipolysis using an in vitro cell model in preadipocyte cells Data from an in vitro adipolysis assay for these compositions were further tested. Theobroma cacao extract(s) or fraction(s) derived from theobroma cacao. The phytochemical constituents or mixtures thereof are derived from Citrus aurantifolia. and extract(s), or fraction(s), or phytochemical constituents, or mixtures thereof. Their corresponding individual components have been shown to have a tendency to exhibit synergy when mixed. showed unexpectedly favorable efficacy in terms of increasing adipolysis when compared with minutes.

[0039] For example, the water extract of Theobroma cacao seeds (TC- 1) and 5) of Citrus aurantifolia fruit peel at a concentration of 13.33 μg / mL. The 0% aqueous ethanol extract (CA-1) reduced adipose tissue levels by 29.52% and 7.12%. At 20 μg / mL, the lysis of Theobroma caca at a ratio of 1:2 was increased. Water extract of Cao seeds (TC-1) and Citrus aurantifolia peel (50% water) Composition-2 containing 47.88% aqueous ethanol extract (CA-1) The increase in polysulfate was calculated from the increases shown by the corresponding individual components. This is significantly better than the additive effect of 36.64% (29.52% + 7.12%). The composition contains the two extracts (TC-1 and CA-1) in different ratios. Compositions 1 & 3 to 5 also show the corresponding individual component concentrations as summarized in Table 6. Theobroma cacao water extract showed synergy when compared to the increases shown by (TC-1) and Citrus aurantifolia (CA-2~CA-5) Other compositions (C6-C19) containing other solvent extracts also showed synergistic pro-additive effects. Theobroma cacao and Citrus au Lait showed polycystic activity (Table 6). Compositions (C-20 to C-65) containing other solvent extracts of T. tifolia are summarized in Table 7. Thus, synergy is observed when compared to the increases exhibited by each of the corresponding individual component concentrations. was presented.

[0040] Interestingly, Theobroma cacao seeds and Citrus aurantifolia fruits Extracts and fractions derived from fruit skins and compositions thereof have been shown to be effective in, for example, browning fat, Thermogenesis, stabilization of energy expenditure, improved thyroid function, increased satiety, discussed below The browning of white adipocytes, such as FGF21, UCP-1 and β3-AR, Other mechanisms to explore obesity and overweight, such as regulating the molecular factors that contribute to it, are They further demonstrated unexpected efficacy in

[0041] Browning of brown adipose tissue (BAT), white adipose tissue (WAT) and energy expenditure Stabilization: Adipose tissue (body fat) is a loosely bound connective tissue made up of fat cells. In humans, adipose tissue is mainly located beneath the skin (subcutaneous adipose tissue). White adipose tissue (WAT) is primarily located in the lining of the body (fat) and around the internal organs (visceral fat). ), also known as white fat, is one of two types of adipose tissue found in mammals. The other type of adipose tissue is brown adipose tissue (BAT). They store energy in the form of fat, which causes pathological hypertrophy during obesity. Pigmented adipose tissue (BAT) is a distinct form of adipose tissue in humans and mammals. T causes the body to dissipate large amounts of chemical energy as heat through a process called thermogenesis. BAT is not only an important biological defense against hypothermia, but also a key regulator of the immune system, which responds to food and drink. Brown adipocytes also play a role in induced thermogenesis. It contains a unique protein known as uncoupling protein 1 (UCP-1). UCP-1 is a short-term circulatory system that is otherwise It is normally used to drive cellular ATP synthesis. This allows the mitochondrial membrane The potential makes BAT capable of transferring heat (thermogenesis), which is related to physical activity. It is possible to change energy expenditure and fuel metabolism without increasing It becomes a weave.

[0042] In recent years, the topic of brown adipose tissue has been gaining attention, as has the browning of WAT, which is also known to be related to white adipose tissue ( The current trend is being rekindled by a number of new studies on the conversion of WAT to beige fat. WAT, derived from several depots, responds to appropriate stimuli and This can trigger a process known as "browning" for the production of ovarian cells. The cells contain multivesicular lipid droplets and multiple mitochondria, and express specific proteins such as UCP-1. Acquire BAT properties by increasing protein expression. "Browning" stimulus Beige adipocytes induced by α-amyloides have significant amounts of mitochondria and UCP-1 These cells are phenotypically similar to classical brown adipocytes in BAT. It has been suggested that adipocytes may have the same thermogenic ability as BAT. FGF21 plays a physiological role in the thermogenic mobilization of WAT. It is also an important regulator of browning. PGC1α is a key transcriptional central regulator of WAT browning The browning of white adipose tissue is also associated with norepinephrine and β3 -Adrenergic receptors (β3AR) are involved, and sympathetic stimulation β3AR activation drives the expression of UCP-1 and other thermogenic proteins in white adipocytes. This sequence of events initiates a signaling cascade that leads to the overexpression of The researchers report that brown adipocytes are white fat cells that have undergone intermediate stages such as beige or brite cells. In addition, thyroid hormones, especially T3, positively regulate UCP-1 synthesis. T3 stimulates UCP-1 synthesis individually or in a synergistic manner to mediate sympathetic It can function in conjunction with stimulation. The activity of T3 is inhibited by T4. A healthy balance of T3 and T4 is therefore important for the browning of white adipocytes.

[0043] FGF-21: Fibroblast growth factor-21 (FGF-21) is a new member of the FGF family. FGF-21 is a major member of the FGF family and is predominantly expressed in the liver. Regulates stasis, insulin sensitivity, ketogenesis, and promotes adipose tissue "browning" Over the past decade, FGF-21 has been implicated in the regulation of obesity and diabetes. Adipose tissue has been shown to be a potential therapeutic target for the treatment of adipose diseases. One of the primary targets of action and one of the important metabolic benefits of FGF-21 is "browning." Emerging evidence supports the role of UCP-1 and other thermoregulatory agents in the autocrine-paracrine system. FGF-21 promotes thermogenesis and white adipose tissue metabolism by upregulating the expression of metabolic genes These results suggest that FGF21 plays a physiological role in the thermogenic mobilization of fat. Increases PGC1α levels in adipose tissue.

[0044] Some compositions selected from Composition-1 to Composition-65 are used to treat mouse 3T3- Fibroblast growth factor-21 (FGF-21) in a cellular assay in L1 preadipocyte cells These compositions were tested in comparison with the corresponding individual components for their ability to increase Data from an in vitro FGF-21 assay derived from Theobroma cacao The extract(s), or fraction(s), or phytochemical constituents or mixtures thereof , extract(s), or fraction(s) derived from Citrus aurantifolia (Acceptable) or tendency to exhibit synergy when mixed with phytochemical ingredients or mixtures thereof The increase in FGF-21 and its associated effects on the immune system, when compared to their respective individual components, suggest that The results showed unexpectedly good efficacy in terms of

[0045] For example, the water extract of Theobroma cacao seeds (TC- 1) and 50% of Citrus aurantifolia fruit peel at a concentration of 3.33 μg / mL. % aqueous ethanol extract (CA-1) contained 10.08% and 18.60% FGF- Theobroma cacao at 5 μg / mL in a 1:2 ratio showed an increase of 21. Water extract (TC-1) and 50% aqueous ethanol of Citrus aurantifolia Composition-2 containing the extract (CA-1) showed an increase in FGF-21 of 44.21%. This was calculated from the increase exhibited by the corresponding individual components by 28.68% (1 This is significantly better than the additive effect of 0.08% + 18.60%). Composition-1 and Composition-2 containing the two extracts (TC-1 and CA-1) -3 to 5 are also represented by their corresponding individual component concentrations, as summarized in Table 8. The inhibition of the TC-10001 was synergistic when compared with that of the TC-10001 ... 1) and other solvent extracts of Citrus aurantifolia (CA-2~CA-5 ) and other compositions containing C-10 and C-15, as well as Theobroma cacao. Compositions containing other solvent extracts of the seeds and peel of Citrus aurantifolia -20 to 23 and compositions-36 to 38 (C-20 to C-23 & C36 to 38) are also The increase exhibited by each of the corresponding individual component concentrations is summarized in Table 8. The results showed a synergistic increase in FGF21 activity when compared with the addition of

[0046] UCP-1: The global epidemic of obesity and other metabolic disorders has prompted scientists to focus on white fat The focus of attention has shifted to adipose tissue (WAT) and its biology. WAT is involved in certain physiological functions. and under pathophysiological conditions, can transform into brown adipose-like tissue. Tissue depots significantly increased gene expression for uncoupling protein 1 (UCP-1), As a result, the "browning" of white fat, which is generally thought to have thermogenic and fat-burning properties, This phenomenon has attracted considerable attention because it changes the function of the energy storage to that of the energy dissipation. UCP-1 is an integral membrane protein found in the inner mitochondrial membrane of brown adipose tissue. It is a functional protein that aids in the process of non-shivering heat production in mammals. Therefore, the researchers' main focus was on eliciting a "browning" response and increasing the U of adipose tissue. The aim of this study is to identify agents that increase the expression and activity of CP-1, which will ultimately contribute to the prevention of obesity and It combats the development of obesity and overweight as well as other metabolic disorders and promotes energy expenditure.

[0047] Therefore, some of the compositions selected from Compositions 1 to 65 are useful for the treatment of mouse 3T3 -L1 preadipocyte cells were examined for uncoupling protein 1 (UCP-1) expression activity. Data from an in vitro UCP-1 assay for these compositions was unexpected. showed a significant increase in UCP-1 expression over controls. Theobroma cacao seed water extract (TC- 1) and a 50% aqueous ethanol extract of the peel of Citrus aurantifolia fruit (C Compositions 1 to 5 containing .A-1) exceeded the control by 38.48% and 34.23%. , with increased UCP-1 expression of 33.81%, 30.71%, and 28.69%. Similarly, theobroma cacao seeds at 1:1 and 2:1 ratios showed good efficacy. 50% methanol extract (TC-4) and Citrus aurantifolia fruit peel Compositions-58 and 59 containing a 50% aqueous ethanol extract (CA-1) of Significant increases in UCP-1 expression were observed over controls, with increases in UCP-1 expression of 24.63% and 11.96%. Therefore, the data summarized in Table 9 show that theobroma cacao Extracts or fractions derived from Citrus aurantifolia and extracts or fractions derived from Citrus aurantifolia A composition containing the extract or fraction may have the potential to upregulate UCP-1 expression, and These results correlate with increased adipose browning, heat production, and stabilization of energy expenditure in the rat. This suggests that:

[0048] β3AR: β3-AR is a β-adrenergic receptor that is located primarily in adipose tissue. Its main functions include regulation of lipolysis and thermogenesis. Classical BAT depots are are highly innervated and respond to, for example, cold exposure and certain dietary chemicals It is activated by centers in the brain in response to certain stimuli, such as exposure to light. It promotes the release of norepinephrine (NE) from nerves. NE is released through the BAT β3-adrenergic receptor When it binds to the β3-AR, it increases the level of intracellular cyclic AMP (cAMP). The addition of glyceryl phosphate promotes lipolysis, and the breakdown of triglycerides promotes the synthesis of uncoupling protein-1. Activation of UC protein-1 (UCP-1) leads to the release of free fatty acids. P-1 uncouples mitochondrial respiration, which is responsible for thermogenesis, thereby increasing BAT lipid In fat cells, mitochondria are prominently abundant, and β3-AR signaling is associated with increased respiration. and non-shivering thermogenesis. In addition to classical brown adipocytes (BAT), beige A similar effect may be seen in bright adipocytes, which are found in WAT depots. However, these are mediated by various stimuli, most notably exposure to cold or β-AR signaling. These activators, as well as peroxisome proliferator-activated receptor activators such as rosiglitazone, Can be "browned" by receptor (PPARγ) agonists. Bright / beige adipocytes Activation of mitochondrial ATPases results in an increase in uncoupled mitochondria, similar to their occurrence in BAT. Therefore, activation of β3-adrenergic receptors (ARs) induces browning, thermogenesis, and This may result in a stabilization of energy expenditure (REE) and an increase.

[0049] Therefore, some representative compositions selected from Compositions-1 to 65 were administered to adipocytes. We examined whether β3-adrenergic receptor (β3AR) expression was increased in mice. In the assay, 3T3-L1 cells treated in vitro with the compositions showed the following results: As summarized in , unexpectedly, there was a significant increase in β3AR expression in cells treated with β-glucose over control. For example, theobroma cacao water extracts at ratios of 1:3, 1:2, and 1:1 showed a significant increase in Extract (TC-1) and Citrus aurantifolia peel 50% aqueous ethanol extract Compositions-1, 2 and 3 (C-1, C-2 and C- 3) increased β3AR expression by 36.17%, 37.47%, and 38.7% over controls, respectively. Similarly, theobroma cacao at 1:2 and 1:1 ratios showed an increase of 51.02%. 50% ethanol extract (TC-2) and Citrus aurantifolia 50% water Compositions-21 & 22 (C-21 & C- 22) showed a 1-fold increase in β3AR expression over controls, as summarized in Table 10. These results were consistent with the results of Citrus Aurante. Extracts derived from Theobroma cacao combined with extracts derived from P. tschonoskii The composition containing the extract can increase the expression of β3AR, as well as promote adipose browning, These results suggest that it may have the ability to increase thermogenesis and lipolysis.

[0050] Dosage Forms: The present invention also provides extracts, fractions and phytochemicals derived from Theobroma cacao. or a combination thereof, and at least one ingredient selected from Citrus Aurantium Dulcis (Citrus Oran) Extracts, fractions and phytochemical constituents or mixtures thereof derived from T. tifolia and optionally a second ingredient selected for pharmaceutical or nutraceutical or nutritional value. Contains at least one component selected from acceptable excipients, carriers and diluents. The present invention provides a synergistic herbal composition that

[0051] The composition prevents, controls or treats obesity, overweight, improves lean body mass, Extracts derived from Theobroma cacao for weight maintenance and lean body mass at least one component selected from the group consisting of a phytochemical component, a fraction and a phytochemical component or a combination thereof; Extracts, fractions and phytochemical constituents derived from Citrus aurantifolia and a second ingredient selected from the mixture thereof, At least one component selected from a nutritionally acceptable excipient, a carrier, and a diluent is optionally added. Optionally, a pharma- ceutically or nutraceutical or nutritionally acceptable excipient or carrier. and diluents are monosaccharides such as glucose, dextrose, fructose, and galactose. Sucrose, maltose, lactose, lactulose, trehalose, cellobiose disaccharides, such as, but not limited to, chitobiose; starch and starch glycols; Modified starches such as sodium phosphate, pregelatinized starch, and soluble starch; and Polycarbohydrates such as other modified starches; yellow dextrin, white dextrin, malt Dextrin, a dextrin produced by hydrolysis of starch or glycogen Phosphorus; sorbitol, mannitol, inositol, xylitol, isomalt, etc. polyhydric or sugar alcohols, including but not limited to; microcrystalline cellulose, hydrolyzed methylcellulose, hydroxypropyl methylcellulose, hydroxyethyl cellulose, etc. Not available, cellulose-based derivatives; Neusilin, Veegum, Talc, Colloidal Dioxide Silicates, such as, but not limited to, silicon; calcium stearate, stearin Metal stearates, such as, but not limited to, magnesium stearate, zinc stearate, etc. Salts; organic acids such as citric acid, tartaric acid, malic acid, succinic acid, lactic acid, and L-ascorbic acid; Polysorbates, fatty acid esters and esters, acacia, carrageenan, guar Natural gums, such as, but not limited to, gum, xanthan gum; B vitamins, nicotine amide, calcium pantothenate, amino acids, casein, gelatin, pectin, agar Proteins such as, but not limited to; sodium chloride, calcium chloride, phosphate Organometallic salts such as, but not limited to, dicalcium sulfate, zinc sulfate, zinc chloride; natural face Aqueous solutions of ingredients, fragrances, Class I & II preservatives and the above listed ingredients, alone or in combination; The solution is selected from an alcohol solution, a hydroalcohol solution, and an organic solution.

[0052] For example, Composition-66 contains 60 g of a water extract of Theobroma cacao seeds (TC-1 ), 30 g of 50% aqueous ethanol extract of Citrus aurantifolia fruit peel ( CA-1), 9g of maltodextrin and 1g of syloid were mixed. Similarly, composition-67 was prepared by dissolving 53.33 g of Theobroma macrocarpa in the presence of ethanol / water. Cacao seed water extract (TC-1), 26.67g of Citrus Aurantifolia 50% aqueous ethanol extract of the peel of the fruit (CA-1), 18g maltodextrin and 2 g of syloid, which were then mixed and dried. was performed in the presence of ethanol / water on 53.2 g of aqueous extract of Theobroma cacao seeds (T C-1), 26.6 g of Citrus aurantifolia fruit peel 50% aqueous ethanol extract (CA-1), 18.2 g of Glusidex-12D and 2 g of Syloides The above ingredients were mixed and then dried to obtain a composition.

[0053] In vivo evaluation of Composition-67 in high-fat diet (HFD)-induced obese animals: In vitro The model contains Theobroma cacao and Citrus aurantifolia. The potent anti-obesity and synergistic effects demonstrated by the compound were demonstrated in an in vivo model of obesity. Obesity was further evaluated in male Sprague-Dawley rats by feeding a high-fat diet for 4 weeks. The control group (G1) was fed normal chow. After a 4-week induction period, the obese rats were divided into groups of 7 animals each into various G2-G3 groups. The animals in the treatment group were randomly assigned to either G4 or G5 groups for an additional 4 weeks. Each was treated with 100 mg / kg (G3) or 300 mg / kg CMC in 10 mL of 0.5% CMC in water. g / kg (G4) body weight composition - 67 or 10 mg sibutramine (G5) orally daily The control group of animals (G2) was supplemented with vehicle (10 mL of 0.5% CMC in water). The weights of individual animals were recorded weekly, and the mean body weights of animals in each group were calculated. Weight gain / change was measured 1 week after the start of treatment compared to the initial weight of each animal. The mean mean age of the HFD control group (G2) was 1.2 years and 1.3 years. In comparison, Composition-67 significantly and dose-dependently inhibited the GABAergic deficiency in high-fat diet-induced obese rats. At the end of the treatment period, the 100 mg / kg and 300 mg / kg 99.5% and 109% of the body weight in the treatment groups supplemented with Composition-67, respectively. showed a 0.1% decrease in body weight gain in the 300 mg / kg dose group. After 2 weeks of treatment, the effect began to show significance. The results of body weight and final proportional body weight changes are summarized in Figures 1A and 1B. These results clearly suggest that Composition-67 has potent anti-obesity activity.

[0054] In addition, for rats in groups G3 and G4 supplemented with Composition 67, The average daily food intake was significantly reduced. Food consumption data are shown in Figure 2. These observations are expressed as the amount of chlorine in the chlorinated water (KJ / day). Oral feeding reduced weight gain and helped maintain a healthy weight in HFD rats, and Studies have shown that it limits dietary calorie consumption through the use of

[0055] At the end of the study, animals were euthanized and their internal organs (retroperitoneal, epididymal, perirenal and mesenteric) were removed. ) Adipose tissue was collected from the rats and weighed. The composition was significantly different when compared to HFD-fed rats. The total fat mass of the group supplemented with Composition-67 was significantly reduced, and the 300 mg of Composition- The 67(G4) supplemented group presented statistical significance (Figure 3). In addition, HF D Formalin-fixed paraffin-embedded adipose tissue compared to control group (G2) rats Microscopic examination of the 28-day supplementation of Group G4 with 300 mg of Composition-67 revealed that It was found that the α-amyloid β ... The findings showed that supplementation with Composition-67 significantly reduced body fat in obese or overweight rats. This shows that.

[0056] After 28 days of addition, serum samples were analyzed for circulating leptin levels. As summarized in Figure 5, the results showed that the schizophrenia of the rats supplemented with Composition-67 was significantly higher than that of the HFD rats. Interestingly, leptin levels in the treatment groups were significantly decreased. The data showed that Composition-67 reduced satiety to that of chow-fed control animals. showed a promising role in regulating food consumption by regulating the This observation was made because rats supplemented with Composition-67 in the study consumed significantly more food. The reason for the reduction can be explained.

[0057] In addition, one interesting observation was that the Composition-67 supplemented rats had significantly higher GI than the HFD rats. The rats that were administered T3 showed improved T3 / T4 balance (Figure 6). It is the active thyroid hormone formed by metabolic conversion from the precursor T4. , the primary regulator of energy homeostasis in the body, which is the body's basal metabolic rate. In addition, T3 also positively influences the stabilization of white fat mass and energy expenditure. It is also an important factor in the process of converting fat cells into brown fat cells. In overweight animals, the T3 / T4 ratio is lower than in non-overweight individuals. In a study, rats supplemented with Composition-67 had a higher T3 / T4 ratio compared to HFD rats. This observation suggests that the herbal composition improved thyroid function in overweight rats. In summary, this observation indicates that supplementation with Composition-67 improved The authors strongly suggest that the thyroid gland stimulates the production of brown fat, which is associated with the above-mentioned thyroid function. These events increased the stabilization of energy expenditure in overweight rats. This provided evidence that this resulted in a reduction in body fat.

[0058] Immunohistochemistry in epididymal adipose tissue showed that in rats supplemented with Composition-67 The presence of UCP-1 stained brown adipocytes in the mice fed solid diet (Figure 7). The rats fed the HFD (G1) or HFD (G2) had brown adipose tissue in their epididymis. This observation therefore does not suggest that Composition-67 is capable of promoting the development of brown adipose tissue. This clearly indicates that it potentially induced the formation of

[0059] The forgoing subject matter includes extracts, fractions, and the like derived from Theobroma cacao. a first component selected from phytochemical components and mixtures thereof; and Extracts, fractions, phytochemical constituents and mixtures thereof derived from T. tifolia The synergistic herbal composition, which includes a combination of the second ingredient, inhibits adipogenesis and promotes lipolysis. It accelerates the process of aging, increases FGF21 production, and increases the expression of UCP-1 and β3-AR. , has been shown to increase fat browning and improve T3 / T4 balance. The composition prevents, controls, or treats obesity and / or overweight, and increases lean body mass. Improves the formation of brown adipose tissue (BAT) and improves the browning of white adipose tissue (WAT). Improves growth, increases basal metabolic rate (BMR) / stabilizes energy expenditure, and promotes heat production Improves health, improves thyroid function, maintains healthy weight, increases satiety and promotes weight loss At least one of the following will be selected from the following: It can be beneficial to obtain health benefits.

[0060] Thus, an important embodiment of the present invention provides a method for preventing and controlling obesity and / or overweight. Control or treat to improve lean body mass and enhance browning of white adipose tissue (WAT) / Improves the formation of brown adipose tissue (BAT) and increases the basal metabolic rate (BMR) / Energy Stabilizes ghee consumption, improves thermogenesis, improves thyroid function, maintains healthy weight, Increases satiety, aids in weight loss, enhances fat loss and helps maintain lean body mass Selected, derived from Theobroma cacao to obtain at least one health benefit. a first component selected from the group consisting of extracts, fractions, phytochemical components and mixtures thereof; Extracts, fractions, phytochemical constituents and their bioavailability derived from Truss aurantifolia and a second ingredient selected from the mixture of:

[0061] In another embodiment, the present invention provides extracts, fractions, botanicals derived from Theobroma cacao. A first component selected from the group consisting of citrus aurantifolia and mixtures thereof. The present invention relates to a method for the preparation of a phytochemical composition comprising the steps of: extracts, fractions, phytochemical components and mixtures thereof derived from A synergistic herbal composition is provided comprising a combination of two components, the concentration of the first component in the composition being: The concentration of the second component varies in the range of 10% to 90% by weight, and the concentration of the second component varies in the range of 90% to 10% by weight. The value varies within the range of

[0062] In another exemplary embodiment, the present invention provides an extract, fraction, or mixture derived from Theobroma cacao. a first ingredient selected from the group consisting of components, phytochemical components and combinations thereof, and a citrus aura Extracts, fractions, phytochemical constituents and mixtures thereof derived from Pseudomonas entifolia are selected from the group consisting of and a second ingredient selected from the group consisting of phenylalanine, ... At least one selected from the group consisting of physiologically or nutritionally acceptable excipients, carriers and diluents. The composition optionally comprises the components:

[0063] In another embodiment, the present invention provides a method for preventing or controlling obesity and / or overweight. Treat and improve lean body mass and browning of white adipose tissue (WAT) / brown adipose tissue Improves the formation of BAT and stabilizes basal metabolic rate (BMR) / energy expenditure, Increases thermogenesis, improves thyroid function, maintains healthy weight, increases satiety, and reduces At least one of the following may be selected from the group consisting of: supporting mass, enhancing fat loss, and maintaining lean body mass. Extracts, fractions and plant extracts derived from Theobroma cacao to obtain additional health benefits. A first component selected from the group consisting of biochemical components and combinations thereof, and a Citrus Aurantii The present invention relates to a method for producing a composition comprising the steps of: extracts, fractions, phytochemical components and mixtures thereof derived from P. folia. The present invention provides a synergistic herbal composition comprising a combination of a second ingredient that is effective in treating a variety of conditions, including medicaments, dietary supplements, and the like. or at least one component selected from nutritionally acceptable excipients, carriers and diluents. Optionally, pharma- ceutically or nutraceutical or nutritionally acceptable excipients, carriers and and diluents are monosaccharides such as glucose, dextrose, fructose, and galactose. ;Sucrose, maltose, lactose, lactulose, trehalose, cellobiose, disaccharides, such as, but not limited to, chitobiose; starch and starch glycols; Modified starches such as sodium phosphate, pregelatinized starch, soluble starch, and others Polycarbohydrates such as modified starches; yellow dextrin, white dextrin, maltodextrin Dextrin, a dextrin produced by hydrolysis of starch or glycogen sorbitol, mannitol, inositol, xylitol, isomalt, etc. polyhydric or sugar alcohols; microcrystalline cellulose, hydroxy Examples of the cellulose acetate derivatives include, but are not limited to, dimethyl cellulose, hydroxyethyl cellulose, and the like. No, cellulose-based derivatives; Neusilin, Veegum, Talc, Colloidal Dioxide silicates, such as, but not limited to, calcium stearate, stearic acid Metal stearates, such as but not limited to magnesium, zinc stearate Organic acids such as citric acid, tartaric acid, malic acid, succinic acid, lactic acid, and L-ascorbic acid; Resorbates, fatty acid esters and esters, acacia, carrageenan, guar gum natural gums, such as, but not limited to, gum, xanthan gum; B vitamins, nicotine Amides, calcium pantothenate, amino acids, casein, gelatin, pectin, agar, etc. Proteins such as, but not limited to; sodium chloride, calcium chloride, diphosphate Organometallic salts, such as, but not limited to, calcium, zinc sulfate, and zinc chloride; natural pigments , fragrances, Class I & II preservatives and the ingredients listed above, alone or in combination, in water. The solvent is selected from an alcohol solution, a water-alcohol solution, and an organic solution.

[0064] In another embodiment, the present invention provides extracts, fractions, plants derived from Theobroma cacao. A first component selected from chemical ingredients and combinations thereof, and Citrus Aurantium The present invention relates to a method for the preparation of a phytochemical composition comprising the steps of: extracts, fractions, phytochemical components and combinations thereof derived from Olia. A synergistic herbal composition is provided comprising a combination of a second ingredient, the extract or fraction being from the leaves, stems, Tender stems, tender twigs, above-ground parts, whole fruit, fruit skin rind, seeds, flower heads, roots, bark , hardwood or whole plant or mixtures thereof. It is obtained from plant parts.

[0065] In another embodiment, the present invention provides extracts, fractions, plants derived from Theobroma cacao. A first component selected from chemical ingredients and combinations thereof, and Citrus Aurantium The present invention relates to a method for the preparation of a phytochemical composition comprising the steps of: extracts, fractions, phytochemical components and combinations thereof derived from Olia. A synergistic herbal composition is provided that includes a combination of second ingredients, the extract or fraction being ethanol. C1-C5 alcohols such as ethanol, methanol, n-propanol, and isopropyl alcohol. acetone, ketones such as methyl isobutyl ketone, dichloromethane and chloroform Chlorinated solvents such as formaldehyde, water and their mixtures, C1-C7 carbonized solvents such as hexane from the group including hydrogen, esters such as ethyl acetate and the like, and mixtures thereof, The composition is prepared using at least one solvent selected from the group consisting of:

[0066] In another embodiment, the present invention provides extracts, fractions, botanicals derived from Theobroma cacao. A first component selected from the group consisting of citrus aurantifolia and mixtures thereof. The present invention relates to a method for the preparation of a phytochemical composition comprising the steps of: extracts, fractions, phytochemical components and mixtures thereof derived from The present invention provides a synergistic herbal composition comprising a combination of two ingredients, the extract or fraction comprising at least To a biologically active marker compound or extract or fraction of one phytochemical constituent and is standardized as a group of phytochemical marker compounds and phytochemical compounds. The concentration range is 0.1% to 99% by weight of the extract.

[0067] In another embodiment, the present invention provides extracts, fractions, botanicals derived from Theobroma cacao. A first component selected from the group consisting of citrus aurantifolia and mixtures thereof. The present invention relates to a method for the preparation of a phytochemical composition comprising the steps of: extracts, fractions, phytochemical components and mixtures thereof derived from The present invention provides a synergistic herbal composition comprising a combination of two ingredients, an extract or fraction, Theobroma capitata. The phytochemical composition of cocoa is standardized to theobromine, with theobromine concentration ranging from , 0.1% to 20% by weight of the composition.

[0068] In another embodiment, the present invention provides extracts, fractions, botanicals derived from Theobroma cacao. A first component selected from the group consisting of citrus aurantifolia and mixtures thereof. The present invention relates to a method for the preparation of a phytochemical composition comprising the steps of: extracts, fractions, phytochemical components and mixtures thereof derived from A synergistic herbal composition comprising a combination of two ingredients, Citrus aurantifolia The extract or fraction is standardized to limonin and the concentration range of limonin is within the range of the composition. The content is 0.1% by weight to 10% by weight.

[0069] In another embodiment, the present invention provides extracts, fractions, plants derived from Theobroma cacao. A first component selected from chemical ingredients and combinations thereof, and Citrus Aurantium The present invention relates to a method for the preparation of a phytochemical composition comprising the steps of: extracts, fractions, phytochemical components and mixtures thereof derived from Olia. A synergistic herbal composition is provided comprising a combination of a second ingredient, the composition(s) being in the form of a dry powder. Form, liquid form, beverage, food, dietary supplement or tablet, capsule, soft chew A dosage form selected from any suitable form, such as a crushable or gummy bear. It has been formulated into

[0070] The composition(s) disclosed above may be used in the form of a health food, i.e. chocolate or Solid foods such as nutritional bars, semi-solid foods such as creams, jams or gels, or refreshers Beverages such as lactic acid bacteria drinks, drops, candies, chewing gum, gummy candies yogurt, ice cream, pudding, soft red bean jelly, jelly, cookies, tea, Specific health products such as soft drinks, juice, milk, coffee, cereals, and snack bars Nutritional / dietary information that can be used to formulate / produce food for health use It can be formulated into a supplement.

[0071] In a further embodiment, the method comprises preventing, controlling, or treating obesity and / or overweight, and reducing fat mass. Improves fat body mass and promotes browning of white adipose tissue (WAT) / brown adipose tissue (BAT) ) formation, increase basal metabolic rate (BMR) and stabilize energy expenditure , Increases Thermogenesis, Improves Thyroid Function, Maintains Healthy Weight, Increases Satiety, Weight Loss and providing a method for improving fat loss and maintaining a lean body, Extracts, fractions, phytochemical constituents and mixtures thereof derived from Theobroma cacao and an extract derived from Citrus aurantifolia. a second component selected from a fraction, a phytochemical component and mixtures thereof; At least one additional component selected from pharma- ceutically acceptable excipients, diluents, and carriers. The present invention includes supplementing a subject with a suitable dose of a synergistic herbal composition, optionally containing nothing.

[0072] In another embodiment, the present invention provides a method for preventing, controlling, or treating obesity and / or overweight, and for reducing fat mass. Improves body weight and promotes browning of white adipose tissue (WAT) / brown adipose tissue (BAT) Improves the formation of fat, increases the basal metabolic rate (BMR) and stabilizes energy expenditure. Increases Thermogenesis, Improves Thyroid Function, Maintains Healthy Weight, Increases Satiety, and Promotes Weight Loss The present invention provides a method for supporting and enhancing fat loss and maintaining lean body mass, the method comprising: , extracts, fractions, phytochemical constituents and mixtures thereof derived from Theobroma cacao and an extract derived from Citrus aurantifolia, and a second component selected from the group consisting of a phytochemical component, a phytochemical component, and mixtures thereof, At least one additional component selected from physiologically acceptable excipients, diluents, and carriers. and optionally supplementing the subject with a suitable dose of a synergistic herbal composition comprising: The obesity treatment is based on the promotion of lipolysis, adipogenesis, inhibition of lipid accumulation, and fibroblast proliferation. Increased fibroblast growth factor-21 (FGF-21), increased uncoupling protein-1 (UCP-1) and increased β3- This includes at least one of the following: increased adrenoceptor (β3-AR).

[0073] In another embodiment, the present invention provides a method for preventing, controlling, or treating obesity and / or overweight. Improves lean body mass and promotes browning of white adipose tissue (WAT) / brown adipose tissue Improves the formation of BAT, increases the basal metabolic rate (BMR) and reduces energy expenditure Improves metabolism, promotes thermogenesis, improves thyroid function, maintains healthy weight, and increases satiety. Helps you lose weight, improves fat loss and maintains lean body mass Extracts, fractions, and other substances derived from Theobroma cacao to obtain the same health benefits. A first ingredient selected from phytochemical ingredients and mixtures thereof and Citrus aurantii The present invention relates to a method for producing a composition comprising the steps of: extracts, fractions, phytochemical components and mixtures thereof derived from P. folia. and a second component selected from pharma- ceutically acceptable excipients, diluents, and carriers. The present invention relates to the use of a synergistic herbal composition, which optionally contains at least one additional ingredient that is provide.

[0074] In another embodiment, the present invention provides a method for preventing, controlling, or treating obesity and / or overweight, and for reducing fat mass. Improves body weight and promotes browning of white adipose tissue (WAT) / brown adipose tissue (BAT) Improves the formation of fat, increases the basal metabolic rate (BMR) and stabilizes energy expenditure. Increases Thermogenesis, Improves Thyroid Function, Maintains Healthy Weight, Increases Satiety, and Weight Loss The present invention provides a method for supporting and enhancing fat loss and maintaining lean body mass, the method comprising: , extracts, fractions, phytochemical constituents and mixtures thereof derived from Theobroma cacao and an extract derived from Citrus aurantifolia, and a second component selected from the group consisting of a phytochemical component, a phytochemical component, and mixtures thereof, At least one additional component selected from physiologically acceptable excipients, diluents, and carriers. and optionally supplementing the subject with a suitable dose of a synergistic herbal composition comprising: The administration of a suitable dose to the subject may be in the form of a sustained release tablet or a bolus of the desired therapeutic To obtain benefits, nanotechnology, microencapsulation, colloidal carrier systems and Sustained release polymer-based coatings with other drug delivery systems including It is being used.

[0075] Those skilled in the art may make modifications to the above embodiments without departing from the broad inventive concept thereof. It will be appreciated that the present invention may be modified in accordance with the teachings of the present invention. The present invention is not limited to the specific embodiments or examples described herein, but may be modified in any manner as defined herein. It is intended to cover modifications that fall within the spirit and scope of the invention as defined herein. The examples presented are intended to illustrate the invention but are not to be construed as limiting the invention in any manner whatsoever. It should not be considered as limiting the scope of the disclosure. EXAMPLES

[0076] Example 1: Preparation of a water extract of Theobroma cacao seeds Dry Theobroma cacao seeds (100g) were finely ground and the powdery raw material was then mixed with water. Extraction with water (700 mL) was performed in a laboratory extractor at room temperature (rt) for 1 h. The extract was filtered. The crude material used was re-extracted twice with water (2 x 500 mL) under similar conditions. The combined extracts were filtered and concentrated under vacuum to give the residue of the aqueous extract as a powder ( TC-1, 14g).

[0077] Example 2: Ethanolic extract and 50% aqueous ethanol extract of Theobroma cacao seeds Preparation of the ingredients Dry Theobroma cacao seeds (100g) were finely ground and the powdery raw material was then mixed with water. Extract with 50% aqueous ethanol (700 mL) in a laboratory extractor at room temperature (rt) for 1 h. The extract was filtered and the raw material used was diluted twice under similar conditions with 50% aqueous ethanol. The combined extracts were filtered and concentrated under vacuum. The residue of the ethanol extract was obtained (TC-2, 11 g).

[0078] Ethanol extract of Theobroma cacao seeds (100g) (TC-3, 4.4g) was obtained by adapting the same procedure as above, using ethanol as the extraction solvent. It was.

[0079] Example 3: Preparation of a 50% aqueous methanol extract of Theobroma cacao seeds Dry Theobroma cacao seeds (100g) were finely ground and the powdery raw material was then mixed with water. Extract with 50% aqueous methanol (700 mL) in a laboratory extractor at room temperature (rt) for 1 h. The extract was filtered and the raw material used was diluted twice under similar conditions with 50% methanol. (2×500 mL). The combined extracts were filtered and concentrated in vacuo. The residue of 50% aqueous methanol extract was obtained (TC-4, 10 g).

[0080] Example 4: Preparation of n-butanol extract of Theobroma cacao seeds Dry Theobroma cacao seeds (100g) were finely ground and the powdery raw material was then mixed with water. Extraction with n-butanol (700 mL) was performed using a laboratory extractor at room temperature (rt) for 1 h. The extract was filtered and the raw material used was diluted twice under similar conditions with n-butanol (2 × 50 The combined extracts were filtered and concentrated under vacuum to give n-butadiene. The residue of the Nol extract was obtained (TC-5, 24.5 g).

[0081] Example 5: Standardization of Theobroma cacao seed extract Various extracts of Theobroma cacao seeds were analyzed for theobromine by HPLC. The results were standardized as follows and are summarized in Table 1.

[0082] [Table 1]

[0083] Example 6: Citrus aurantifolia fruit peel 50% aqueous ethanol & ethanol Preparation of le extract Raw material (100 g) of dried Citrus aurantifolia fruit peel, finely ground The powder was then extracted with 1:1 ethanol / water ( The extract was filtered and the raw material used was run twice under similar conditions. The extract was re-extracted with 1:1 ethanol / water (2 x 500 mL). The combined extracts were filtered. The residue of 50% aqueous ethanol was concentrated under vacuum to give a brown powder (CA-1, 2 1g). Total flavonoids by UV: 9.92%.

[0084] The ethanol extract (CA-2, 9.5 g) was prepared using ethanol as the extraction solvent. This was obtained by adapting the procedure described previously.

[0085] Similarly, the raw material from dried whole fruit of Citrus aurantifolia (10 0 g) was subjected to the same extraction procedure as above and extracted with 50% aqueous alcohol as a brown powder (15 g). The extract was obtained.

[0086] Example 7: Preparation of aqueous extract of Citrus aurantifolia fruit peel The dried fruit peel of Citrus aurantifolia (100 g) was finely ground and powdered. The processed material was extracted with water (700 mL) in a laboratory extractor at room temperature (rt) for 1 h. The extract was filtered and the raw material used was washed twice with water (2 x 500 mL) under similar extraction conditions. The combined extracts were filtered and concentrated under vacuum to give a brown powder. The residue of the water extract was obtained (CA-3, 21 g).

[0087] Example 8: Preparation of 50% aqueous methanol extract of Citrus aurantifolia fruit peel Manufacturing The dried fruit peel of Citrus aurantifolia (100 g) was finely ground and powdered. The processed material was extracted with 50% aqueous methanol (7 The extract was filtered and the raw material used was washed twice under similar conditions with 500 mL of water. The extracts were then re-extracted with 0% aqueous methanol (2×500 mL). The combined extracts were filtered and Concentration under vacuum gave the residue of the 50% aqueous methanol extract as a brown powder (C. A-4, 30g).

[0088] Example 9: Preparation of butanol extract of Citrus aurantifolia fruit peel The dried fruit peel of Citrus aurantifolia (100 g) was finely ground and powdered. The processed material was extracted with n-butanol (700 mL) in a laboratory extractor for 1 h at room temperature (rt). The extract was filtered and the raw material used was extracted twice under similar conditions with n-butanoic acid. The combined extracts were filtered and concentrated under vacuum. The butanol extract residue was obtained as a brown powder (CA-5, 7 g).

[0089] Example 10: Standardization of Citrus Aurantifolia Extract The limonin content of various extracts of Citrus aurantifolia was determined by HPLC analysis. The results are summarized in Table 2.

[0090] [Table 2]

[0091] Example 11: Composition of Theobroma cacao water extract (TC-1) and Citrus au Lait Preparation of Lantifolia extracts (CA-1 to CA-5) Composition-1(C-1) Composition-1 was mixed with Theobroma cacao water extract ( TC-1) and Citrus aurantifolia 50% aqueous ethanol extract (CA- 1) was mixed to prepare the mixture. Composition-2(C-2) Composition-2 was mixed with Theobroma cacao water extract ( TC-1) and Citrus aurantifolia 50% aqueous ethanol extract (CA- 1) was mixed to prepare the mixture. Composition-3(C-3) Composition-3 was mixed with Theobroma cacao water extract ( TC-1) and Citrus aurantifolia 50% aqueous ethanol extract (CA- 1) was mixed to prepare the mixture. Composition-4(C-4) Composition-4 was mixed with Theobroma cacao water extract ( TC-1) and Citrus aurantifolia 50% aqueous ethanol extract (CA- 1) was mixed to prepare the mixture. Composition-5(C-5) Composition-5 was mixed with Theobroma cacao water extract ( TC-1) and Citrus aurantifolia 50% aqueous ethanol extract (CA- 1) was mixed to prepare the mixture. Composition-6(C-6) : Composition-6 was mixed with Theobroma cacao water extract ( TC-1) and Citrus aurantifolia ethanol extract (CA-2) were mixed. It was prepared by mixing. Composition-7(C-7) : Composition-7 was mixed with Theobroma cacao water extract ( TC-1) and Citrus aurantifolia ethanol extract (CA-2) were mixed. It was prepared by mixing. Composition-8(C-8) : Composition-8 was mixed with Theobroma cacao water extract ( TC-1) and Citrus aurantifolia ethanol extract (CA-2) were mixed. It was prepared by mixing. Composition-9(C-9) : Composition-9 was mixed with Theobroma cacao water extract ( TC-1) and Citrus aurantifolia water extract (CA-3) were mixed. It was prepared by the following. Composition-10(C-10) : Composition-10 was mixed with Theobroma cacao water extract in a ratio of 1:2. The extract (TC-1) was mixed with Citrus aurantifolia water extract (CA-3). It was prepared by Composition-11(C-11) : Composition-11 was added to theobroma cacao water extract in a 1:1 ratio. The extract (TC-1) and Citrus aurantifolia water extract (CA-3) were mixed. It was prepared by Composition-12(C-12) : Composition-12 was mixed with Theobroma cacao water extract in a ratio of 2:1. The extract (TC-1) was mixed with Citrus aurantifolia water extract (CA-3). It was prepared by Composition-13(C-13) : Composition-13 was added to theobroma cacao water extract in a ratio of 3:1. The extract (TC-1) was mixed with Citrus aurantifolia water extract (CA-3). It was prepared by Composition-14(C-14) : Composition-14 was added to theobroma cacao water extract in a ratio of 1:2. (TC-1) and Citrus aurantifolia 50% aqueous methanol extract (C .A-4) was mixed to prepare the composition. Composition-15(C-15) : Composition-15 was added to theobroma cacao water extract in a 1:1 ratio. (TC-1) and Citrus aurantifolia 50% aqueous methanol extract (C .A-4) was mixed to prepare the composition. Composition-16(C-16) : Composition-16 was mixed with Theobroma cacao water extract in a ratio of 2:1. (TC-1) and Citrus aurantifolia 50% aqueous methanol extract (C .A-4) was mixed to prepare the composition. Composition-17(C-17) : Composition-17 was added to theobroma cacao water extract in a ratio of 1:2. Extract (TC-1) and Citrus Aurantifolia Butanol Extract (CA-5) It was prepared by mixing the above. Composition-18(C-18) : Composition-18 was mixed with Theobroma cacao water extract in a 1:1 ratio. Extract (TC-1) and Citrus Aurantifolia Butanol Extract (CA-5) It was prepared by mixing the above. Composition-19(C-19) : Composition-19 was mixed with Theobroma cacao water extract in a ratio of 2:1. Extract (TC-1) and Citrus Aurantifolia Butanol Extract (CA-5) It was prepared by mixing the above.

[0092] Example 12: Composition of 50% aqueous ethanol extract of Theobroma cacao (TC-2) Preparation of Citrus aurantifolia extracts (CA-1~CA-5) Composition-20(C-20) : Composition-20, Theobroma cacao 50 in a ratio of 1:3 % aqueous ethanol extract (TC-2) and Citrus aurantifolia 50% aqueous ethanol extract (TC-3). It was prepared by mixing with ethanol extract (CA-1). Composition-21(C-21) : Composition-21, 50% Theobroma cacao in a 1:2 ratio % aqueous ethanol extract (TC-2) and Citrus aurantifolia 50% aqueous ethanol extract (TC-3). It was prepared by mixing with ethanol extract (CA-1). Composition-22(C-22): Composition-22, 50% Theobroma cacao in a 1:1 ratio % aqueous ethanol extract (TC-2) and Citrus aurantifolia 50% aqueous ethanol extract (TC-3). It was prepared by mixing with ethanol extract (CA-1). Composition-23(C-23) : Composition-23, 50% Theobroma cacao in a ratio of 2:1 % aqueous ethanol extract (TC-2) and Citrus aurantifolia 50% aqueous ethanol extract (TC-3). It was prepared by mixing with ethanol extract (CA-1). Composition-24(C-24) : Composition-24, 50% Theobroma cacao in a ratio of 3:1 % aqueous ethanol extract (TC-2) and Citrus aurantifolia 50% aqueous ethanol extract (TC-3). It was prepared by mixing with ethanol extract (CA-1). Composition-25(C-25) : Composition-25, Theobroma cacao 50 in a ratio of 1:2 % aqueous ethanol extract (TC-2) and Citrus aurantifolia ethanol extract It was prepared by mixing with the extract (CA-2). Composition-26(C-26) : Composition-26, 50% Theobroma cacao in a 1:1 ratio % aqueous ethanol extract (TC-2) and Citrus aurantifolia ethanol extract It was prepared by mixing with the extract (CA-2). Composition-27(C-27) : Composition-27, 50% Theobroma cacao in a 2:1 ratio % aqueous ethanol extract (TC-2) and Citrus aurantifolia ethanol extract It was prepared by mixing with the extract (CA-2). Composition-28(C-28) : Composition-28, 50% Theobroma cacao in a ratio of 1:3 % aqueous ethanol extract (TC-2) and Citrus aurantifolia aqueous extract (C .A-3) was mixed to prepare the composition. Composition-29(C-29) : Composition-29, 50% Theobroma cacao in a ratio of 1:2 % aqueous ethanol extract (TC-2) and Citrus aurantifolia aqueous extract (C .A-3) was mixed to prepare the composition. Composition-30(C-30) : Composition-30, Theobroma cacao 50 in a 1:1 ratio % aqueous ethanol extract (TC-2) and Citrus aurantifolia aqueous extract (C .A-3) was mixed to prepare the composition. Composition-31(C-31) : Composition-31, 50% Theobroma cacao in a ratio of 2:1 % aqueous ethanol extract (TC-2) and Citrus aurantifolia aqueous extract (C .A-3) was mixed to prepare the composition. Composition-32(C-32) : Composition-32, 50% Theobroma cacao in a ratio of 3:1 % aqueous ethanol extract (TC-2) and Citrus aurantifolia aqueous extract (C .A-3) was mixed to prepare the composition. Composition-33(C-33) : Composition-33, 50% Theobroma cacao in a ratio of 1:2 % aqueous ethanol extract (TC-2) and Citrus aurantifolia 50% aqueous ethanol extract (TC-3) It was prepared by mixing with ethanol extract (CA-4). Composition-34(C-34) : Composition-34, 50% Theobroma cacao in a 1:1 ratio % aqueous ethanol extract (TC-2) and Citrus aurantifolia 50% aqueous ethanol extract (TC-3) It was prepared by mixing with ethanol extract (CA-4). Composition-35(C-35) : Composition-33, 50% Theobroma cacao in a ratio of 2:1 % aqueous ethanol extract (TC-2) and Citrus aurantifolia 50% aqueous ethanol extract (TC-3) It was prepared by mixing with ethanol extract (CA-4). Composition-36(C-36) : Composition-36, 50% Theobroma cacao in a ratio of 1:2 % aqueous ethanol extract (TC-2) and Citrus aurantifolia butanol extract It was prepared by mixing with the extract (CA-5). Composition-37(C-37) : Composition-37, 50% Theobroma cacao in a 1:1 ratio % aqueous ethanol extract (TC-2) and Citrus aurantifolia butanol extract It was prepared by mixing with the extract (CA-5). Composition-38(C-38) : Composition-38, 50% Theobroma cacao in a ratio of 2:1 % aqueous ethanol extract (TC-2) and Citrus aurantifolia butanol extract It was prepared by mixing with the extract (CA-5).

[0093] Example 13: Theobroma cacao extracts (TC-3, TC-4 & T.C-5) and Preparation of the Compositions of Citrus Aurantifolia Extracts (CA-1~CA-5) Composition-39(C-39) : Composition-39 was mixed with Theobroma cacao ethanol in a ratio of 1:2. Nol extract (TC-3) and Citrus aurantifolia 50% aqueous ethanol extract It was prepared by mixing with the extract (CA-1). Composition-40(C-40) : Composition-40, Theobroma cacao ethanol in a 1:1 ratio Nol extract (TC-3) and Citrus aurantifolia 50% aqueous ethanol extract It was prepared by mixing with the extract (CA-1). Composition-41(C-41) : Composition-41 was mixed with Theobroma cacao ethanol in a ratio of 2:1. Nol extract (TC-3) and Citrus aurantifolia 50% aqueous ethanol extract It was prepared by mixing with the extract (CA-1). Composition-42(C-42) : Composition-42 was mixed with Theobroma cacao ethanol in a ratio of 1:2. Nol extract (TC-3) and Citrus aurantifolia ethanol extract (C. A-2) was mixed to prepare the above mixture. Composition-43(C-43) : Composition-43 was mixed with Theobroma cacao ethanol in a 1:1 ratio. Nol extract (TC-3) and Citrus aurantifolia ethanol extract (C. A-2) was mixed to prepare the above mixture. Composition-44 (C-44) : Composition-44 was mixed with Theobroma cacao ethanol in a ratio of 2:1. Nol extract (TC-3) and Citrus aurantifolia ethanol extract (C. A-2) was mixed to prepare the above mixture. Composition-45(C-45) : Composition-45 was mixed with Theobroma cacao ethanol in a ratio of 1:2. Nol extract (TC-3) and Citrus aurantifolia water extract (CA-3) It was prepared by mixing the above. Composition-46(C-46) : Composition-46 was mixed with Theobroma cacao ethanol in a 1:1 ratio. Nol extract (TC-3) and Citrus aurantifolia water extract (CA-3) It was prepared by mixing the above. Composition-47(C-47) : Composition-47 was mixed with Theobroma cacao ethanol in a ratio of 2:1. Nol extract (TC-3) and Citrus aurantifolia water extract (CA-3) It was prepared by mixing the above. Composition-48(C-48) Composition-48 is a Theobroma cacao ethanol extract ( TC-3) and Citrus aurantifolia 50% aqueous methanol extract (CA- 4) in a 1:2 ratio. Composition-49(C-49) : Composition-49 was mixed with Theobroma cacao ethanol in a 1:1 ratio. Nol extract (TC-3) and Citrus aurantifolia 50% aqueous methanol extract It was prepared by mixing with the extract (CA-4). Composition-50(C-50) : Composition-50, Theobroma cacao ethanol in a ratio of 2:1 Nol extract (TC-3) and Citrus aurantifolia 50% aqueous methanol extract It was prepared by mixing with the extract (CA-4). Composition-51(C-51) : Composition-51 was mixed with Theobroma cacao ethanol in a ratio of 2:1. nol extract (TC-3) and Citrus aurantifolia butanol extract (C. A-5) was mixed. Composition-52(C-52) : Composition-52 was mixed with Theobroma cacao ethanol in a 1:1 ratio. nol extract (TC-3) and Citrus aurantifolia butanol extract (C. A-5) was mixed. Composition-53(C-53) : Composition-53 was mixed with Theobroma cacao ethanol in a ratio of 2:1. nol extract (TC-3) and Citrus aurantifolia butanol extract (C. A-5) was mixed. Composition-54(C-54) : Composition-54, Theobroma cacao 50 in a ratio of 1:2 % methanol extract (TC-4) and Citrus aurantifolia aqueous extract (CA -3) was mixed to prepare the product. Composition-55(C-55) : Composition-55, Theobroma cacao 50 in a 1:1 ratio % methanol extract (TC-4) and Citrus aurantifolia aqueous extract (CA -3) was mixed to prepare the product. Composition-56(C-56) : Composition-56, Theobroma cacao 50 in a ratio of 2:1 % methanol extract (TC-4) and Citrus aurantifolia aqueous extract (CA -3) was mixed to prepare the product. Composition-57(C-57) : Composition-57, Theobroma cacao 50 in a ratio of 1:2 % methanol extract (TC-4) and Citrus aurantifolia 50% ethanol It was prepared by mixing with the extract (CA-1). Composition-58(C-58) : Composition-58, Theobroma cacao 50 in a 1:1 ratio % methanol extract (TC-4) and Citrus aurantifolia 50% ethanol It was prepared by mixing with the extract (CA-1). Composition-59(C-59) : Composition-59, Theobroma cacao 50 in a ratio of 2:1 % methanol extract (TC-4) and Citrus aurantifolia 50% ethanol It was prepared by mixing with the extract (CA-1). Composition-60(C-60) : Composition-60 and Theobroma cacao in a 1:2 ratio. Nol extract (TC-5) and Citrus aurantifolia water extract (CA-3) It was prepared by mixing the above. Composition-61(C-61) : Composition-61 is mixed with Theobroma cacao in a 1:1 ratio. Nol extract (TC-5) and Citrus aurantifolia water extract (CA-3) It was prepared by mixing the above. Composition-62(C-62) : Composition-62 was mixed with Theobroma cacao in a ratio of 2:1. Nol extract (TC-5) and Citrus aurantifolia water extract (CA-3) It was prepared by mixing the above. Composition-63(C-63): Composition-63 was mixed with Theobroma cacao in a ratio of 1:2. Nol Extract (TC-5) and Citrus Aurantifolia 50% Ethanol Extract (CA-1) was mixed with Composition-64(C-64) : Composition-64 was mixed with Theobroma cacao in a 1:1 ratio. Nol Extract (TC-5) and Citrus Aurantifolia 50% Ethanol Extract (CA-1) was mixed with Composition-65(C-65) : Composition-65 in a 2:1 ratio with Theobroma cacao. Nol Extract (TC-5) and Citrus Aurantifolia 50% Ethanol Extract (CA-1) was mixed with

[0094] Example 14: Composition Formulation Composition-66(C-66) Composition-66 contains 60 g of theobroma cacao water extract ( TC-1), 30g of Citrus aurantifolia 50% aqueous ethanol extract ( CA-1), 9g of maltodextrin and 1g of syloid were mixed. Ta. Composition-67(C-67) Composition-67 has a viscosity of 53.33 in the presence of ethanol / water. g of Theobroma cacao water extract (TC-1), 26.67 g of Citrus Aurante 50% aqueous ethanol extract of Medicago sativa (CA-1), 18g maltodextrin and and 2 g of syloid were mixed and dried to obtain a composition. Composition-68(C-68) Composition-68 is prepared by dissolving 53.2 g of ethanol / water in the presence of water. Theobroma cacao water extract (TC-1), 26.6g of Citrus Aurantium Olia 50% aqueous ethanol extract (CA-1), 18.2g of Glusidex-12 D and 2 g of Syloid were mixed and dried to obtain the composition.

[0095] Example 15: General procedure for adipogenesis inhibition assay Mouse 3T3-L1 preadipocytes (50,000 cells / well in 500 μL) were cultured at 48- The cells were seeded in well cell culture plates and incubated at 37°C in a humidified atmosphere of 5% CO2 with 10% DMEM (Dulbecco's Modified Eagle Medium) containing FBS The cells were maintained in a confluent state (~2 days) in 100% ethanol. After that, 0.5 mM 3-isobutyl-1-methylbutyric acid was added to DMEM containing 10% FBS. Contains Santin (IBMX), 1 μM dexamethasone, and 500 nM insulin The cells were treated with different concentrations of the test samples for 48 hours in differentiation medium (DM). The cell culture medium was diluted with 100% DMEM containing the relative concentrations of the test samples and 10% FBS. Change to post-DM containing 10 nM insulin along with the test samples at the relative concentrations Post-DM was replaced with new ones every 48 hours until day 6. Eight days after the initiation of differentiation, cells was subjected to Oil Red O staining.

[0096] Oil Red O staining: Aspirate the medium and add 0.5 mL of 10% formaldehyde to each well. and incubated at room temperature for 2 hours. The formaldehyde was removed from the wells and 0.25 mL of 60% isopropanol was added and the plate was allowed to dry completely. A microliter of Red Oil O was added and allowed to incubate in the dark at room temperature for 20 minutes. The red oil O was aspirated and the plates were washed four times with distilled water. The plates were dried completely and incubated for 15 Add 0 μL of 100% isopropanol, mix thoroughly and dispense 75 μL into 96-well plates. Transfer to an assay plate and read at 550 nm using a Spectramax5e plate reader. The absorbance was measured at 1000 nm. The inhibition rate of adipogenesis was calculated using the following formula:

[0097]

number

[0098] Using the above procedure, all compositions were screened for their inhibition of adipogenesis. The results are shown in Tables 3, 4 & 5.

[0099] Table 3: Theobroma cacao extract (TC-1) and Citrus aurantifolia Adipogenic activity of compositions containing extracts (CA-1 to CA-5) [Table 3]

[0100] Table 4: Theobroma cacao extract (TC-2) and Citrus aurantifolia Adipogenic activity of compositions containing extracts (CA-1 to CA-4) [Table 4]

[0101] Table 5: Theobroma cacao extracts (TC-3, TC-4, TC-5) and Citra A composition containing S. aurantifolia extract (CA-1 to CA-5) adipogenic activity [Table 5]

[0102] Example 16: General procedure for augmentation of adipolysis assay Mouse 3T3-L1 preadipocytes (50,000 cells / well in 500 μL) were cultured at 48- The cells were seeded in well cell culture plates and incubated at 37°C in a humidified atmosphere of 5% CO2 with 10% Cells were maintained in DMEM containing FBS until confluent (~2 days). Then, the cells were incubated in DMEM containing 10% FBS with 0.5 nM IBMX, 1 μM dextran, and The cells were incubated for 48 h in differentiation medium (DM) containing methasone and 500 mM insulin. Differentiation was allowed to occur for 24 hours. The cell culture medium was 100 ml of DMEM with 10% FBS. The post-DM was then changed to 48 nM insulin for 6 days. On day 7, the medium was aspirated from the wells and phenol red was removed. The cells were washed with 600 μL of DMEM without 2% BSA (50 μL). Test samples of different differentiation concentrations were prepared in DMEM medium without phenol red. The cells were treated with 50 μL of ethanol and incubated at 37°C for 4 hours in a CO2 incubator. After incubation, 25 μL of cell-free supernatant was removed from the wells. The wells were then mixed into a 96-well assay plate and processed for the glycerol assay.

[0103] Glycerol Assay: 25 microliters of standard or sample was added to a 96-well plate. In a 100 μL assay plate, add 100 μL of glycerol reagent [ATP: 20.65 mg, M gCl2: 46.20 mg, N-ethyl-N-(3-sulfopropyl)-m-anisidine -Sodium salt: 31.10mg, Aminoantipyro l): 1.90 mg, glycerol kinase: 10.2 μL, glycerol oxidase 125 μL of IgG1 and 62.5 μL of HRP were dissolved in 50 mL of 1x PBS. The plate was incubated at room temperature for 15 minutes. The absorbance was measured on a Spectramax5e plate. The seven-point glycerol standard curve was measured at 550 nm using a reader. The increase in lipolysis was estimated using the following formula: did.

[0104]

number

[0105] Using the above procedure, all compositions were screened for their increased lipolysis. The results are shown in Tables 6 & 7.

[0106] Table 6: Theobroma cacao extract (TC-1) and Citrus aurantifolia Adipolytic activity of compositions containing extracts (CA-1 to CA-4) [Table 6]

[0107] Table 7: Theobroma cacao extracts (TC-2 and TC-3) and citrus aubergine extracts Adipopolis of a composition containing Lantifolia extract (CA-1 to CA-5) Cis activity [Table 7]

[0108] Example 17: General procedure for FGF21 assay Mouse 3T3-L1 preadipocytes (150,000 cells / well in 3 mL) were cultured in 6-well plates. The cells were seeded onto cell culture plates and incubated at 37°C in a humidified atmosphere with 5% CO2 in 10% FB. The cells were maintained in DMEM medium containing 0.1% ethanol and 4.5 g / L glucose. After allowing the cells to become confluent (~2 days), they were cultured in DMEM with 10% FBS at 0.5 It contained 1 mM IBMX, 1 μM dexamethasone, and 500 nM insulin. Differentiation was induced for 48 hours using differentiation medium (DM) containing 10% F Change to post-DM containing 100 nM insulin in DMEM with BS. The post-DM was replaced with new one every 48 hours until day 6. On day 7, the medium was removed from the wells. Aspirate the medium from the spleen and use DMEM medium containing 1% FBS without phenol red. The cells were then washed twice with DMEM containing 1% FBS (total volume of 1 mL). The cells were treated with test samples (50 μL) of different differentiation concentrations at 4 °C and incubated at 4 °C for 1 h at CO2 The plates were then incubated at 37°C for another 48 hours. Cell-free supernatants were harvested from the wells and subjected to FGF21 analysis by ELISA. The FGF21 ELISA (R&D Systems Cat#DY2539) was , was performed according to the manufacturer's protocol.

[0109] The rate of increase in FGF21 was calculated using the following formula:

[0110]

number

[0111] Using the above procedure, selected compositions are assessed for their increase in FGF-21 over a control. The results of screening are shown in Table 8.

[0112] Table 8: Contains Theobroma cacao extract and Citrus aurantifolia extract FGF21 activity of the composition [Table 8]

[0113] Example 18: General procedure for UCP-1 assay Mouse 3T3-L1 preadipocytes (150,000 cells / well in 3 mL) were cultured in 6-well plates. The cells were seeded onto cell culture plates and incubated at 37°C in a humidified atmosphere with 5% CO2 in 10% FB. The cells were maintained in DMEM medium containing 0.1% ethanol and 4.5 g / L glucose. After allowing the cells to become confluent (~2 days), they were cultured in DMEM with 10% FBS at 0.5 It contained 1 mM IBMX, 1 μM dexamethasone, and 500 nM insulin. Differentiation was induced for 48 hours using differentiation medium (DM) containing 10% F Change to post-DM containing 100 nM insulin in DMEM with BS. The post-DM was replaced with new one every 48 hours until day 6. On day 7, the medium was removed from the wells. Aspirate the medium from the spleen and use DMEM medium containing 1% FBS without phenol red. The cells were then washed twice with DMEM containing 1% FBS (total volume of 1 mL). The cells were treated with test samples (50 μL) of different differentiation concentrations at 4 °C and incubated at 4 °C for 1 h at CO2 The plates were incubated at 37° C. for an additional 48 hours.

[0114] Western Blot: After incubation, place the cell culture plate on an ice tray and rinse twice with 1x PBS. Wash. Add 80 microliters of lysis buffer (10 mM Tris-HCl pH 7. 4, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 10 μg / mL A Protinin, 10 μg / mL leupeptin, 1% Triton X-100, 1 mM Na F, 1 mM Na3VO4, 0.5% sodium deoxycholate, and 1 μM statin) was added to each well, and the cell lysates were collected in microfuge tubes. The microfuge tube was sonicated for 1 min. Cellular proteins were extracted at 21952 x g. After centrifugation, the cells were harvested and protein was determined using the Pierce BCA protein assay. Quantification using a kit (Thermo Scientific Cat# 23225) Protein samples were subjected to SDS-polyacrylamide gel electrophoresis, The separated proteins were analyzed by wet blotting. Briefly, 10 μg of protein was transferred onto a nitrocellulose membrane. The mixture was loaded onto a gel (10% resolution) and electrophoresed at approximately 100 V for 1 hour and 40 minutes. At the end, the transfer system was placed in a 4°C chamber (100 V for 2 h) to nitrosate. After transfer, UCP-1 was incubated for 18 hours at 4°C. The anti-UCP-1 antibody (Thermo Scientific Cat#PA1-2 β-actin was probed with 4894 (1:10000 dilution). Incubated with anti-β-actin antibody (Sigma Cat#A4700-100 The antibodies were probed with mouse anti-goat peroxidase-conjugated secondary antibody (1:10000 dilution, 1 μL). Antibody (Jackson Immuno Research Cat#205-035-1 08, diluted 1:10000) was added and incubated at room temperature for 30 minutes. The chemiluminescent substrate (Thermo Scientific Cat#34080) was used for blot analysis. The lot was developed and imaged on a Bio-Rad molecular imaging device (model: ChemiDOC XRS+). Images were captured using a 3D microscope. The intensity of the UCP-1 protein band was measured using a Carestr microscope. Relative indices were calculated using eam MI software and normalized using β-actin. The percentage of UCP-1 expression over control was calculated using the following formula:

[0115]

number

[0116] Using the above procedure, the selected composition is evaluated for its % UCP-1 expression over the control. The results of screening are shown in Table 9.

[0117] Table 9: Composition of Theobroma cacao extract and Citrus aurantifolia extract UCP-1 expression [Table 9]

[0118] Example 19: General procedure for β3AR assay Mouse 3T3-L1 preadipocytes (150,000 cells / well in 3 mL) were cultured in 6-well plates. The cells were seeded onto cell culture plates and incubated at 37°C in a humidified atmosphere with 5% CO2 in 10% FB. The cells were maintained in DMEM medium containing 0.1% ethanol and 4.5 g / L glucose. After allowing the cells to become confluent (~2 days), they were cultured in DMEM with 10% FBS at 0.5 It contained 1 mM IBMX, 1 μM dexamethasone, and 500 nM insulin. Differentiation was induced for 48 hours using differentiation medium (DM) containing 10% F Change to post-DM containing 100 nM insulin in DMEM with BS. The post-DM was replaced with new one every 48 hours until day 6. On day 7, the medium was removed from the wells. Aspirate the medium from the spleen and use DMEM medium containing 1% FBS without phenol red. The cells were then washed twice with DMEM containing 1% FBS (total volume of 1 mL). The cells were treated with test samples (50 μL) of different differentiation concentrations at 4 °C and incubated at 4 °C for 1 h at CO2 The plates were incubated at 37° C. for an additional 48 hours.

[0119] Western Blot: After incubation, place the cell culture plate on an ice tray and rinse twice with 1x PBS. Wash. Add 80 microliters of lysis buffer (10 mM Tris-HCl pH 7. 4, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 10 μg / mL A Protinin, 10 μg / mL leupeptin, 1% Triton X-100, 1 mM Na F, 1 mM Na3VO4, 0.5% sodium deoxycholate, and 1 μM statin) was added to each well, and the cell lysates were collected in microfuge tubes. The microfuge tube was sonicated for 1 min. Cellular proteins were extracted at 21952 x g. After centrifugation, the cells were harvested and protein was determined using the Pierce BCA protein assay. Quantification was performed using a kit (Thermo Scientific Cat#23225). Protein samples were subjected to SDS-polyacrylamide gel electrophoresis and analyzed. The separated proteins were then subjected to wet blotting. Briefly, 10 μg of protein was transferred onto a cellulose membrane. The gel was placed on a 10% gel column (10% decomposition) and electrophoresed at approximately 100 V for 1 hour and 40 minutes. Instead, the transfer system was placed in a 4°C chamber (100 V for 2 hours) to obtain a nitrocell. After transfer, β3AR was incubated for 18 hours at 4°C. Anti-β3AR antibody (Biorbyt Cat#orb221343, 1:500 dilution) β-actin was probed with anti-β-actin antibody incubated at room temperature for 2 hours. Cutin antibody (Sigma Cat#A4700-100uL, 1:10000 dilution) was used. Peroxidase-conjugated mouse anti-goat secondary antibody (Jackson Immunosorbent Assay (JAMSTEC)) was used for the search. No Research Cat#205-035-108, 1:10000 dilution) The mixture was incubated at room temperature for 30 minutes. Finally, chemiluminescent substrate (Thermo S The blots were developed using Bio-Rad's Scientific Cat#34080. Images were captured using a molecular imaging device (model: ChemiDOC XRS+). The intensity of the β3AR protein band was analyzed using Carestream MI software. The relative index was calculated and normalized with β-actin. was calculated using the following formula:

[0120]

number

[0121] Using the above procedure, all compositions were screened for β3AR expression above their controls. The results are shown in Table 10.

[0122] Table 10: β3AR composition of Theobroma cacao and Citrus aurantifolia Expression [Table 10]

[0123] Example 20: Theobroma in a high-fat diet-induced obesity model in Sprague-Dawley rats Cacao water extract (TC-1) and Citrus aurantifolia 50% aqueous ethanol Composition-6 containing Nol extract (CA-1), maltodextrin and syroid In vivo anti-obesity activity of 7

[0124] Induction: Selected healthy Sprague-Dawley rats were randomly assigned to normal controls (N=7) or to high-fat diets. They were randomly assigned to the high-fat diet-induced obesity group (n=34) and the high-fat diet-induced obesity group (n=35). All animals were fed a high-fat diet to prevent the dietary intervention during the first 4-week induction period. At the end of the induction period, animals were classified as overweight based on body weight. They were randomized into four groups (n=7): G2-overweight controls; G3-overweight controls; -Composition-67(100mg / Kg, po), G4-Composition-67(300mg / K g, po) and G5-sibutramine (10 mg / Kg, po).

[0125] Treatment: A 4-week induction phase followed by 4 weeks of treatment with the assigned test substance or vehicle. The animals were treated orally (by oral gavage). 100 mg (G3) or 300 mg / kg ( G4) supplemented with Composition-67 (C-67) or sibutramine at 10 mg / kg body weight The control group of animals received vehicle (10 mL of 0.5% CMC in water) during this period. During the treatment phase, all animals received standard rodent chow until the end of the study. was supplied.

[0126] Parameters evaluated: Body weights of individual animals were recorded weekly for the entire duration of the study. The average body weight was measured. Weight gain during the treatment phase and at the end of treatment, respectively, compared with the initial body weight. The gains were calculated weekly, and the results are shown in Figures 1A and 1B.

[0127] Dietary calorie consumption: The total amount of food consumed by the experimental rats during the treatment phase of the study was recorded. The total amount of feed consumed over the 28 days was averaged to estimate daily feed consumption (in grams). The average feed consumption (grams) was 3.43KJ / gram for normal solid feed and 3.43KJ / gram for high-fat feed. The amount of energy (KJ / gram) provided by the fat diet (5.15 KJ / gram) The average daily calorie consumption (KJ / day) by the experimental group was , as shown in Figure 2.

[0128] The animals were then euthanized and the visceral (retroperitoneal, epididymal, perirenal and mesenteric) adipose tissue was removed from the rats. The samples were taken from the samples and weighed on an electronic balance with a sensitivity of 0.01 g (Mettler To (Ledo, Columbus, OH). Observations regarding changes in visceral fat weight are shown in Figure 1. It is summarized in 3.

[0129] Morphometry of adipose tissue: Epididymal adipose tissue from individual animals was diluted with 10% Paraffin-embedded tissues were cut into 5 μm sections and the sections were subjected to standard processing as follows: Hematoxylin-eosin stained tissue sections were microscopically Observation was performed at 20x magnification (Axio Scope A1, Carl Zeiss GmbH, Jena, Germany). We estimated the pixel size of fat cells and used 0. The area of ​​each cell was estimated using a converted scale of 1694 μm. Adipocyte size data is shown in Figure 4.

[0130] Serum biomarker evaluation: At the end of the study, blood samples were taken from all animals. Separate the serum from the liquid sample and use a commercially available ELISA kit (Leptin ELISA kit, EMD Millipore, Billerica, MA; T3 and T4 ELISA kits Using a 100-μg / kg / day kit (Calbiotech, EL Cajon, CA), leptin, triiodothyronine, and ribozyme were measured. Dothyronine (T3) and thyroxine (T4) were analyzed. The assay was performed according to the instructions provided in the product. Serum leptin data are summarized in Figure 5. Thyroid hormone balance (T3 / T4) , were calculated for all animals and the results are summarized in Figure 6.

[0131] Adipocyte immunohistochemistry: Immunohistochemistry for UCP-1 was performed using DAB staining according to the kit instructions. The colorimetric method was performed on paraffin-embedded epididymal adipose tissue (EMD Millipore , Billerica, MA). Tissue classification using UCP-1 antibody (Invitrogen, C Arlsbad, Calif.), followed by reaction with streptavidin-conjugated HRP. Finally, diaminobenzedene (DAB) was used The antibody-specific color reaction was developed using a fluorochrome plated ... erver.Z1 microscope (Carl-Zeiss, Oberkochen, German Representative micrographs of UCP-1 stained epididymal adipose tissue sections captured using a 3D microscope. The truth is shown in Figure 7.

Claims

1. Synergistic herbal composition for preventing, controlling, or treating obesity and / or overweight Improves lean body mass and enhances browning of white adipose tissue (WAT) / brown adipose tissue Improves the formation of BAT, increases basal metabolic rate (BMR) and stabilizes energy expenditure Improves metabolism, promotes thermogenesis, improves thyroid function, maintains healthy weight and increases satiety Assists in weight loss, promotes fat loss and maintains lean body mass. Extracts, fractions, and other substances derived from Theobroma cacao to obtain at least one health benefit. a first component selected from the group consisting of a citrus aura component, a phytochemical component and mixtures thereof; Extracts, fractions, phytochemical constituents and mixtures thereof derived from Pseudomonas entifolia are selected from the group consisting of A synergistic herbal composition comprising a combination of selected second ingredients.

2. The extract or fraction is subjected to extraction of at least one phytochemical component reference in the extract or fraction. Standardize to a reference marker compound or biological activity marker, and standardize to a phytochemical marker compound or The concentration range of the group of phytochemical compounds is 0.1% to 99% by weight of the extract. %. The synergistic composition of claim 1 .

3. The weight of the derivatives of Theobroma cacao seeds varies from 10% to 90%, while Citra The weight of the induced components in the peel of the fruit of S. aurantifolia varies from 90% to 10%. The synergistic composition of claim 2.

4. The Theobroma cacao seed extract or fraction is standardized to theobromine and The composition according to claim 3, wherein the concentration of bromine is in the range of 0.1% to 20% by weight of the composition. Multiplicative composition.

5. The Citrus aurantifolia fruit peel extract or fraction is standardized for limonin. The method according to claim 3, wherein the concentration of limonin is in the range of 0.1% to 10% by weight of the composition. The synergistic composition described above.

6. Selected from a pharma- ceutical or nutraceutical or nutritionally acceptable excipient, carrier or diluent 10. The synergistic composition of claim 1, optionally comprising at least one component selected from the group consisting of glycerol, glycerol, terpenes ...

7. The pharma- ceutical, nutraceutical or nutritionally acceptable excipient, carrier or diluent is Monosaccharides such as glucose, dextrose, fructose, galactose, etc.; maltose, lactose, lactulose, trehalose, cellobiose, chitobio disaccharides, such as, but not limited to, starch; starch glycolate; Modified starches such as thorium, pregelatinized starch, soluble starch, and other modified starches Polycarbohydrates such as starch; yellow dextrin, white dextrin, maltodextrin phosphates, alginates, etc., produced by hydrolysis of starch or glycogen Dextrins selected from sorbitol, mannitol, inositol, xylitol, isomo polyhydric or sugar alcohols, such as, but not limited to, cellulose; microcrystalline cellulosic acid; cellulose, hydroxypropyl methylcellulose, hydroxyethyl cellulose, etc. Cellulose-based derivatives including but not limited to: Neusilin, Veegum, Talc, Colloid silicates, such as, but not limited to, silicate dioxide; calcium stearate; Metal stearates such as, but not limited to, magnesium stearate and zinc stearate. Phosphate salts: Citric acid, tartaric acid, malic acid, succinic acid, lactic acid, L-ascorbic acid, etc. Organic acids such as polysorbates, fatty acid esters and esters, acacia, carrageenan, etc. Natural gums such as guar gum, xanthan gum, etc.; B vitamins, nicotine, Mido, calcium pantothenate, amino acids, casein, gelatin, pectin, agar Unspecified protein; Sodium chloride, calcium chloride, sodium hydroxide, potassium chloride These include, but are not limited to, calcium hydroxide, potassium hydroxide, dicalcium phosphate, zinc sulfate, and zinc chloride. Inorganic metal salts, unspecified; natural pigments, fragrances, Class I & Class II preservatives and those listed above The components listed above may be used alone or in combination in aqueous, alcoholic, hydroalcoholic, or organic solutions.

7. The synergistic composition of claim 6 selected from a solution.

8. The extract, fraction or phytochemical component is selected from the group consisting of leaves, stems, tender stems, tender twigs, aerial parts, , whole fruit skin, fruit skin rind, seeds, flower heads, roots, bark, hardwood or whole plant or obtained from at least one plant part selected from the group including mixtures thereof; 2. The synergistic composition of claim 1.

9. The extract, fraction or phytochemical component is preferably prepared by subjecting the extract, fraction or phytochemical component to an alcohol-based solvent such as ethanol, methanol, n-propanol, C1 to C5 alcohols such as isopropyl alcohol; acetone, methyl isobutyl ketone, etc. Ketones such as toluene, chlorinated solvents such as dichloromethane and chloroform, water, hexane C1-C7 carbohydrates such as ethyl acetate and the like; esters such as ethyl acetate and the like; and mixtures thereof, 2. The synergistic composition of claim 1.

10. The composition(s) may be in a dry powder form, a liquid form, a beverage, a water dispersible formulation, a food product, , dietary supplements or tablets, capsules, soft chewy or gummy bears The pharmaceutical composition according to any one of claims 1 to 9, which is formulated into a dosage form selected from any suitable form such as The synergistic composition described above.

11. The composition may be in the form of a health food, i.e. a solid food such as chocolate or a nutritional bar, water, Semi-solid foods or refreshments such as beverages, creams, jams or gels that can be dispersed in water. Beverages such as milk drinks, lactobacillus drinks, drops, candies, chewing gum, gummy candies, yogurt, and other beverages. Yogurt, ice cream, pudding, soft red bean jelly, jelly, cookies, tea, soft Drinks, juices, milk, coffee, cereals, snack bars and the like Nutritional value that can be formulated / made into food formulations for specific health uses The synergistic composition of claims 1 to 9, formulated into a nutritional / dietary supplement.

12. Preventing, controlling or treating obesity and / or overweight, improving lean body mass, and Improves browning of adipose tissue (WAT) / Improves brown adipose tissue (BAT) formation and promotes basal Increases metabolic rate (BMR) / stabilizes energy expenditure, increases heat production, and stimulates the thyroid gland. Improves function, maintains healthy weight, increases satiety, aids weight loss, and enhances fat loss The health benefits selected from the group consisting of increasing blood flow and maintaining lean body mass, and promoting lipolysis. , inhibition of adipogenesis, inhibition of lipid accumulation, and increase in fibroblast growth factor-21 (FGF-21) , increased uncoupling protein 1 (UCP-1) and β3-adrenergic receptor (β3-AR 2. The synergistic composition of claim 1, wherein the synergistic composition is obtained by at least one of the following: thing.

13. The present invention relates to a method for preventing, controlling or treating obesity and / or overweight in humans or animals, and for the treatment of such conditions. Improves fat body weight and enhances browning of white adipose tissue (WAT) / brown adipose tissue (BA) T) Improves metabolism, increases basal metabolic rate (BMR) and stabilizes energy expenditure , Increases thermogenesis, Improves thyroid function, Maintains healthy weight, Increases satiety, 1. A method for assisting in weight loss, enhancing fat loss, and maintaining lean body mass, said method comprising: Extracts, fractions, phytochemical constituents and mixtures thereof derived from Theobroma cacao and an extract derived from Citrus aurantifolia. a second component selected from a fraction, a phytochemical component and mixtures thereof; and at least one additional agent selected from the group consisting of pharma- ceutically acceptable excipients, diluents, and carriers. Supplementing a subject with a suitable dose of a synergistic herbal composition, optionally containing additional ingredients. A method comprising:

14. Promotes lipolysis, inhibits adipogenesis, and inhibits lipid accumulation in humans and animals It increases fibroblast growth factor-21 (FGF-21) and uncoupling protein (UCP -1) A method for increasing expression and increasing β3-adrenergic receptors (β3-AR) The method provides extracts, fractions, phytochemical components and extracts derived from Theobroma cacao. and mixtures thereof; and a first component selected from Citrus aurantifolia. A second component selected from the group consisting of the derived extracts, fractions, phytochemical components and mixtures thereof. The combination may include at least one selected from pharma- ceutically acceptable excipients, diluents, and carriers. The synergistic herbal composition, optionally containing at least one additional ingredient, is provided in a suitable dosage form. A method comprising feeding the human or animal.

15. The supply of a suitable dose to said human or animal is achieved in the form of a tablet, capsule, sustained release dosage form, or by using nanotechnology, microencapsulation, or other methods to obtain the desired therapeutic benefit. Controlled release through techniques including hydration, colloidal carrier systems and other drug delivery systems.

15. The method according to claim 13 or 14, wherein a reactive polymer-based coating is used.

16. Preventing, controlling or treating obesity and / or overweight, improving lean body mass, and Improves browning of adipose tissue (WAT) / Improves brown adipose tissue (BAT) formation and promotes basal Increases metabolic rate (BMR) / stabilizes energy expenditure, increases heat production, and improves thyroid function. Improves glandular function, maintains healthy weight, increases satiety, aids in weight loss, and promotes fat loss Extracts, fractions, and compositions derived from Theobroma cacao for weight gain and maintenance of lean body mass. A first component selected from phytochemical components and mixtures thereof, and Citrus Aurante The present invention relates to a method for producing a composition comprising the steps of: extracts, fractions, phytochemical components and mixtures thereof derived from Pseudomonas aeruginosa. The combination of the second component and the pharma- ceutically acceptable excipients, diluents, and carriers. A synergistic herbal composition optionally containing at least one additional ingredient selected from use.

Citation Information

Patent Citations

  • Preparation of repellent of insect

    JP1980049304A

  • Hair tonic and method for nursing hair by using the same

    JP2004115465A

  • Method for extracting limonene

    JP2005029491A

  • Diet composition

    JP2006265219A

  • Scalp and hair nutrient liquid and method for producing the same

    JP2007246403A